Reconstruction of orbital wall fracture : An experimental and clinical study by Kontio, Risto
Departments of Oral and Maxillofacial Surgery 
Helsinki University Central Hospital 
Institutes of Dentistry and Clinical Medicine, Helsinki University 
Institute of Biomedicine/ Anatomy, Helsinki University 
 
 
 
 
 
Reconstruction of Orbital Wall Fracture 
An experimental and clinical study 
 
 
Risto Kontio 
 
 
 
 
 
 
 
 
 
 
Academic dissertation 
 
To be presented, with the permission of the Medical Faculty of the University of Helsinki, 
for public examination in the Auditorium Faltin of the Helsinki University Central Hospital, 
Kasarmikatu 11–13 on 23th September 2005 at 12 noon. 
 
Helsinki 2005 
 
 
 2
Supervised by: 
Professor Christian Lindqvist, MD, DDS, PhD  
Department of Oral and Maxillofacial Surgery, 
Helsinki University Hospital, Helsinki, Finland 
 
Professor Yrjö T. Konttinen, MD, PhD  
Department of Medicine,  
Helsinki University Hospital, Helsinki, Finland 
 
Professor Ismo Virtanen, MD, PhD 
Institute of Biomedicine/Anatomy 
Helsinki University, Helsinki, Finland 
 
Reviewed by: 
Docent Matti Lamberg, MD, DDS, PhD 
Oral and Maxillofacial Department/ Department of Otorhinolaryngology 
Kuopio University Hospital, Kuopio Finland 
 
Professor Kyösti Oikarinen, DDS, PhD 
Department of Oral and Maxillofacial Surgery, 
Oulu University Hospital, Oulu, Finland 
 
Opponent 
Docent Kalle Aitasalo, MD, DDS, PhD 
Department of Otorhinolaryngology - Head and Neck Surgery 
Turku University Hospital, Turku, Finland 
 
 
Risto Kontio 
ISBN 952-91-9213-4 (nid.) 
ISBN 952-10-2661-8 (PDF) 
http://ethesis.helsinki.fi 
Yliopistopaino 
Helsinki 2005 
 
 
 3
to my family, Ulla, Ilari, Riikka, Sirke and Karri 
 
 
 4
CONTENTS 
List of original publications    6 
Abbreviations     7 
1. Introduction     8 
2. Review of the literature    9 
2.1. Anatomy of orbit, nature and clinical findings of fractures  9 
2.1.1. Anatomy     9 
2.1.2. Mechanism of orbital wall fracture    10 
2.1.3. Clinical findings of orbital fractures   11 
2.2. Finite element model (FEM)    12 
2.3. Implant materials for orbital reconstruction   13 
2.3.1. Autogenous grafts    17 
2.3.1.1. Autogenous bone    17 
2.3.2. Allogeneic grafts    18 
2.3.3. Xenografts     19 
2.3.4. Alloplastic materials    19 
2.3.4.1. Nonresorbable     19 
2.3.4.2. Resorbable    22 
2.4. Tissue repair     25 
2.4.1. Osteogenesis, osteoinduction, osteoconduction  25 
2.4.2. Wound healing    26 
2.4.3. Peri-implant connective tissue capsule    28 
3. Aims of the study     29 
4. Materials and methods     30 
4.1. Experimental studies (I, III, VI)    31 
4.1.1. Animals, anaesthesia, follow-ups   31 
4.1.2. Operative techniques    31 
4.1.3. Implants     32 
4.1.4. Macroscopic evaluation and radiographics  34 
4.1.5. Material characterization    34 
4.1.6. Histology and immunohistochemistry   37 
4.1.7. Electron microscopy    38 
4.1.8. Statistics     39 
4.2. Clinical studies (II, IV)    40 
 
 
 5
4.2.1. Implants     40 
4.2.2. Operative techniques    40 
4.2.3. Clinical examinations    41 
4.2.4. Computed tomography and magnetic imaging  41 
4.3. Finite element analysis (VI)    42 
5. Results      44 
5.1. Experimental studies (I, III, VI)    44 
5.1.1. Macroscopic findings    44 
5.1.2. Radiographic findings    46 
5.1.3. Strength and crystallinity findings   47 
5.1.4. Histology and immunohistochemical findings  52 
5.1.5. Transmission and scanning electron microscopy findings 55 
5.2. Clinical studies (II, IV)    56 
5.2.1. Clinical results with resorbable PDS implant (II)  56 
5.2.2. Clinical results with autogenous iliac crest graft (IV) 57 
5.2.3. Radiographic findings    58 
5.3. Finite element analysis (V)    60 
6. Discussion     67 
7. Conclusions     79  
8. Summary      81 
9. Acknowledgements     83 
10. References     85 
11. Original publications     105 
 
 
 6
LIST OF ORIGINAL PUBLICATIONS: 
 
The present study is based on the following publications. 
 
I Kontio R, Salo A, Suuronen R, Lindqvist C, Meurman JH, Virtanen I. Fibrous 
wound repair associated with biodegradable poly-L/D-lactide copolymer 
implants: study of the expression of tenascin and cellular fibronectin. J Mater 
Sci Mater Med 9: 603-609. 1998. 
 
II Kontio R, Suuronen R, Salonen O, Paukku P, Konttinen YT, Lindqvist C. 
Effectiveness of operative treatment of internal orbital wall fracture with 
polydioxanone implant. Int J Oral Maxillofac Surg 30: 278-285. 2001. 
 
III Kontio R, Suuronen R, Konttinen YT, Hallikainen D, Lindqvist C, Kommonen 
B, Kellomäki M, Kylmä T, Virtanen I, Laine P. Orbital floor reconstruction with 
poly-L/D-lactide implants: clinical, radiological and immunohistochemical study 
in sheep. Int J Oral Maxillofac Surg 33: 361-368. 2004. 
 
IV Kontio RK, Laine P, Salo A, Lindqvist C, Suuronen R. Reconstruction of 
internal orbital wall fracture with iliac crest free bone graft; clinical, CT and 
MRI follow up study. Plast Reconstr Surg. Accepted for publication.  
 
V Kontio R, Al-Sukhun J, Lindqvist C. Orbital Stress Analysis. Part I: Simulation 
of orbital deformation following a blunt injury by finite element analysis 
method. Int J Oral Maxillofac Surg. Accepted for publication. 
 
VI Kontio R, Ruuttila P, Lindroos L, Suuronen R, Salo A, Lindqvist C, Virtanen I, 
Konttinen YT. Biodegradable polydioxanone and poly(L/D)lactide implants: an 
experimental study on peri-implant tissue response. Int J Oral Maxillofac Surg 
Accepted for publication. 
 
The above articles will be referred to in the text by their Roman numerals. 
 
 
 7
ABBREVIATIONS  
ABC  Avidin-biotin-peroxidase complex 
APAAP  Alkaline phosphatase – anti-alkaline phosphatase  
CT  Computerized tomography 
Da  Dalton (g/mol) 
DSC  Differential scanning calorimetry 
FEM  Finite element modelling 
HA  Hydroxyapatite 
Mn  Number-average molecular weight (g/mol) 
MW  Weight-average molecular weight (g/mol) 
Mv  Viscosity average molecular weight (g/mol) 
MRI  Magnetic resonance imaging 
N   Newton (kgm/s2) 
Pa  Pascal (N/m2) 
PDS  Polydioxanone 
PGA   Polylactide acid or polyglycolide 
PLA  Polylactide acid or polylactide 
PLLA   Poly-L-lactide 
PLDLA  Poly-L/D-lactide 
PLDLA 96/4  Poly-L/D-lactide 96/4 
PLDLA 85/15  Poly-L/D-lactide 85/15 
PLDLA 96/70   Poly-L/D-lactide 96/4 mesh sheet with poly-L/DL-lactide 
70/30 frame 
RT  Room temperature 
Sil  Silicone 
s.c.   Subcutaneous 
SR   Self-reinforced 
Tg  Glass transition temperature (°C) 
Tm  Melting temperature (°C) 
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1. INTRODUCTION 
Trauma to the orbit can result in considerable facial deformity and at the same time 
affect both vision and the nervous system of the face. Orbital bone fracture is in most 
cases open defect fracture, and this distinguishes it from other facial bone fractures. 
Rehabilitation of the patient requires an understanding both of the factors that cause 
changes in the form and function of the orbit and intra-orbital and intra-ocular tissues, 
and of the methods and materials available for their repair. There is general consent that 
the ideal material for repairing the orbital floor should be rigid enough to the support 
orbital contents. It should restore the original orbital form and volume, be easy to size 
and shape, inexpensive, readily available and most importantly, biocompatible. In short, 
it should be safe and user-friendly so that even inexperienced surgeons can handle it. 
Until recently the treatment of choice for repairing orbital floor fractures has been 
autogenous bone grafting. While these grafts provide a "gold standard" for 
reconstructions, they are complicated in routine clinical use.  
Alloplastic materials have been gaining popularity for reconstruction of the internal 
orbit because of their ease of use and the fact that they involve no donor-site morbidity. 
However, alloplastic materials have been used with caution, because some of them can 
provoke unpredictable foreign body reactions. As material science advances, these 
materials are acquiring more and more of the properties mentioned above. It is the 
responsibility of the surgeon to recognise the diversity of the materials available and to 
apply them selectively in clinical use.  
It was this backround which led us to investigate the current methods and materials 
available for the repair of orbital fractures and to try to clarify the entire situation. 
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2. REVIEW OF THE LITERATURE 
2.1 Anatomy of orbit, nature and clinical findings of fractures 
2.1.1. Anatomy 
The bony orbit has been described as a hollow pyramid made up of seven bones: 
maxilla, zygoma, sphenoid, ethmoidal bone, frontal bone, lacrimal bone, and palatine 
bone (Figure 1). It is divided into three parts from anterior to posterior. The anterior 
orbit is the frame and the area immediately posterior to it. The middle third of the orbit 
is composed of thin bone, which is anatomically very weak. The posterior third of the 
orbit is constructed of thick bone and incorporates the superior and inferior orbital 
fissures and the optic foramen.  
The supraorbital section of the frame is composed of the strong inferior margin of the 
frontal bone. Laterally and inferiorly, the orbital rim consists of a portion of zygomatic 
bone. The nasoethmoidal region represents the medial rim of the orbit and extends from 
the junction of the maxilla with the zygoma to the frontomaxillary suture. The anterior 
limb of the medial canthal ligament inserts on the anterior lacrimal crest. 
 
 
Figure 1. The right orbit viewed from 
the front. The orbit is surrounded by 
seven cranial bones (in bold):  
1.= Maxilla, 2.= Zygomatic bone, 3.= 
Orbital aspect of greater wing of Sphenoid, 
4.=  Orbital process of Ethmoid bone, 5.= 
Lesser wing of Sphenoid, 6.= Maxillary 
process of Frontal bone, 7.= Nasal bone, 
8.= Posterior Lacrimal bone, 9.= Anterior 
Lacrimal crest, 10.= Orbital process of 
Palatine bone.
The middle third includes four walls (lateral, inferior, medial, and superior). The orbital 
floor (inferior wall) represents a large area of anatomic weakness. The floor has an 
average thickness of 0.27 mm and is weakened further by the groove for the infraorbital 
nerve (Jones and Evans 1967). The orbital roof is a thin extension of the supraorbital 
rim and is composed of the greater and lesser wings of the sphenoids. The medial wall 
is formed largely by the thin orbital plate of the ethmoid bone. The lateral wall consists 
of the orbital process of the zygomatic bone and the greater wing of the sphenoid. The 
floor inclines superiorly at a 30 degree angle from anterior to posterior. From lateral to 
medial, the floor inclines at 45 degrees to merge with the thin bone of the ethmoidal 
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area. The complex relation creates a convex inferior and medial middle third with a 
concave posterior third immediately behind these.  
 
2.1.2. Mechanism of orbital wall fracture 
The anterior and middle thirds of the orbit are involved in fracture displacement, in 
effect acting as a shock absorber and protecting the posterior third of the orbit from 
severe displacement. Pfeiffer (1943) stated that from the nature of the blowout fracture 
it is evident that the force the eyeball is transmitted
to the walls of the orbit, resulting in fractures of the thin structures (Figure 2). As a 
distinct entity, differing from the zygomaticomaxillary complex fracture, the term 
orbital "blowout fracture" was introduced by Converse and Smith (1957) and refers to a 
fracture of the orbital floor without an associated fracture of the orbital rim.  
 
 
 
 
Figure 2. View in the sagittal plane of 
an orbit. Only the orbital walls are 
fractured in a pure orbital blowout fracture. 
This may be caused by a blunt force 
directed at the bony orbital rim or at 
intraorbital soft tissue, leading to an open 
defect fracture.
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Smith and Regan (1957) agreed with Pfeiffer (1943) stating that a blowout fracture is 
caused by an impact to the orbital soft tissue, producing a momentary increase in 
intraorbital pressure. This is supported by other investigations (Converse et al. 1967, 
Rhee et al. 2002). This mechanism of blowout fracture (an increase in hydraulic 
pressure) has been questioned by a number of authors. According to these, when struck 
by a trauma force, the inferior orbital rim is sufficiently resilient to transmit the force to 
the orbital floor, and this may produce distant stress fractures of the orbital walls, while 
the rim rebounds without fracturing (Fujino and Makino 1980, Burm at al. 1999). 
Fujino (1974), in a series of experiments, on a dried human skull without orbital 
contents, demonstrated that a brass striker weighing 420 g with a flat silicone plate, 
when dropped onto the infraorbital margin from a height of 15 cm, produced a linear 
fracture of the orbital floor. When the weight was dropped from a height of 20 cm, a 
punched-out fracture in the convex portion of the orbital floor was produced. Both of 
these fractures occurred without fracture of the orbital rim. This is known as the bone 
transmission (buckling) theory. It seems that both mechanisms produce orbital floor 
fractures but that the orbital floor fracture may occur with lower forces by the hydraulic 
than by the transmission mechanism (Waterhouse et al. 1999, Ahmad et al. 2000, 
Ahmad et al. 2003). 
Because of the complex structure of the orbital walls, the fracture patterns vary 
considerably in their location as well as in their degree of severity. The most common 
site of a blowout fracture is the orbital floor (Tong et al. 2001). The floor, the roof and 
the medial and lateral walls are sometimes all involved in high-energy fractures. 
 
2.1.3. Clinical findings of orbital fractures 
The clinical findings vary but may include periorbital oedema as well as enophthalmos 
and diplopia (Greenwald et al. 1974, Catone et al. 1988, Tong et al. 2001). 
Enophthalmos is the result of a number of causative factors. It may occur when the 
periorbita is ruptured and the orbital fat escapes into the maxillary sinus (Putterman 
1991) or it may be related to the traumatic atrophy of fat resulting from haematoma and 
a low grade inflammatory process (Putterman 1991). 
On the other hand, enophthalmos may also result when the different intraorbital 
structures are entrapped in the fracture site, or it may be due to enlargement of the orbit 
resulting from the fracture and the outward displacement of the orbital walls (Pfeiffer 
1943, Manson et al. 1986, Jin et al. 2000). In their retrospective study, Gilbard and 
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coworkers (1985) reported that enophthalmos occurred in an estimated 22% of patients 
with orbital wall fractures.   
Binocular diplopia is one of the common symptoms of trauma involving the orbit. It is 
a result of deviation of the visual axes. The deviation can be caused by several factors. 
Entrapment of the soft tissue structures in the fracture area can interfere with muscle 
function (Hammerschlag et al. 1982). Connective tissue derangement inside the orbit 
can induce impaired globe mobility (Koorneef and Zonneveld 1987). Displacement of 
orbital walls resulting in alteration of the origin of the extraocular muscles may also 
modify the visual axes. Tessier (1986) suggests that diplopia is caused by nerve injury 
leading to oculomotor imbalance. Any damage to the cranial nerves III, IV and VI may 
result in binocular diplopia.  
Infraorbital nerve injury is a common consequence of internal orbital wall fracture. It 
has been reported that 25% to 75% of patients experience some degree of infraorbital 
sensory disturbance after internal orbital wall fracture (Bartkowski and Krzystkowa 
1982, Tong et al. 2001). 
 
2.2. Finite element model (FEM) 
The morphology of a bone is influenced by its mechanical environment and loading 
history (Hylander 1977, Lanyon 1987, Al-Sukhun 2003). This also applies to the orbit, 
and it has been suggested that the adaptive response to the functional matrix of the 
primate orbit is reflected in its morphology (Ravosa et al. 2000). Although treatment of 
orbital fractures has a moderate success rate, the long-term clinical significance of 
orbital deformation through implant treatment is still unknown. The possibility that 
orbital deformation and the resulting stresses may be a source of implant failure cannot 
be excluded. While intra-orbital techniques i.e. strain gauges provide a "gold standard" 
for measurements of stresses / forces, they are complex and unsuitable for clinical use. 
This problem, however, may in part be overcome by numerical modelling techniques, 
such as finite element analysis (FEA). 
 
Why use FEA? 
Insights into orbital deformation / loading have been gained from measurements of 
regional surface strain in living macaques (Ravosa et al. 2000). The extent to which 
these observations can be extrapolated to human beings is uncertain because of the 
conspicuous differences in the morphology and function between the species. 
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Currently, the direct measurement of bone strain in living human subjects using 
electrical strain gauges is impractical. Photoelastic measurements have also been 
performed using physical models of other bony structures such as the mandible (Ralph 
and Caputo 1975, Mongini et al. 1979, Standlee et al. 1981) but this technique is of 
limited quantitative value. As in the majority of experimental stress methods, its main 
disadvantage is that it is not appropriate for analysing strain under in vivo conditions. 
However, the method is non-destructive and enables the investigator to visualise the 
distribution of surface strains. 
The most common approach has been to use mathematical modelling, where it is a 
much easier task to specify the locations and orientations of putative muscle tension 
vectors in three-dimensional space. While a few mathematical models have been 
reported to investigate bony structures such as the mandible and femur, no attempts 
have been made to build a mathematical model to study the deformation of the orbit. In 
these models, it has been assumed that the bone is a rigid structure, and as such behaves 
according to static equilibrium theory (Gysi 1921, Robinson 1946, Hylander 1975). 
Mathematical models necessarily assume structural rigidity and concentricity in the 
sagittal view, factors which complicate the analysis and limit their usefulness. Such 
restrictions encourage the development of models which are more representative of 
non-rigid, inhomogeneous structures, and which allow the simulation of wide areas of 
muscle attachment (Korioth and Versluis 1997, Al-Sukhun 2003). As an alternative, 
indirect mathematical approach, the finite element modelling technique offers the 
advantage of being able to model structures with intricate shapes and indirectly 
quantify their complex mechanical behaviour at any theoretical point.  
 
2.3. Implant materials for orbital reconstruction 
There is general consent that the ideal material for orbital floor repair should be strong 
enough to support the orbital contents, inexpensive, readily available, easy to contour, 
resorbable and most importantly biocompatible.  
One of the factors that has had a direct impact on the evolution of surgical management 
of internal orbital fractures is the availability of numerous biomaterials for 
reconstructing the bony contours and restoration of the proper orbital volume. The 
reconstruction materials used for internal orbital fracture treatment are listed in Table 1. 
The main characteristics of the implant materials are listed in Tables 2. A and B.  
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Table 1. 
Basically five different implant materials are available for orbital wall reconstruction. 
 
Tissue grafts 
 
Autogenous grafts 
 
Allogeneic grafts Xenografts  
Same individual Same species but 
separate genotype 
(=allograft, homograft) 
Another species 
-Biocoral 
-Bone 
-Dermis 
-Bone  
-Cartilage 
-Dermis  
-Dura mater 
-Fascia 
-Bone  
-Cartilage 
-Dermis  
-Dura mater 
-Fascia 
 
Synthetic alloplastic materials 
 
Nonresorbable                   Resorbable 
Nonmetal: 
-Bioactive glass 
-Hydroxyapatite 
-Polyethylene 
-Silicone 
-Teflon 
Metal: 
-Titanium 
-Vitallium 
-Polydioxanone 
-Polyglycolides  
-Polylactides 
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Table 2. A. 
Autogenous -, allogeneic - and xenograft materials for orbital wall reconstruction. Advantages 
and disadvantages of implant materials are illustrated. FF=Very favourable F=Favourable, 
U=Unfavourable, UU=Very unfavourable.  
 
 Autogenous grafts Allogeneic grafts Xenografts 
 Bone Cartilage Bone Dura Fascia/ 
cartilage 
Bone Dermis 
Resistance to infection, 
long term FF FF F F F F U 
Facilitates bone 
growth FF ─ F F F F U 
No foreign body 
reaction FF FF F F F UU UU 
Adequate mechanical 
properties FF U FF F U FF UU 
No second operative 
site UU UU FF FF FF FF FF 
No donor site 
morbidity U U FF FF FF FF FF 
Easy to harvest F F FF FF FF FF FF 
Easy to mold U F U F F U F 
Adequate in quantity FF F FF FF FF FF FF 
Low resorption U F UU F F UU F 
No risk of 
transmission of 
infectious agent 
FF FF U U U U U 
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Table 2. B. 
Alloplastic implant materials for orbital wall reconstruction. Advantages and disadvantages of 
implant materials are illustrated. FF=Very favourable F=Favourable, U=Unfavourable, 
UU=Very unfavourable.  
  
 Alloplastic, nonresorbable  material Alloplastic, resorbable  material 
 
Tit Sil Teflon HA BAG PDS PLLA PLDLA PGA PLA/ PGA 
Resistance to 
infection F U U U F U U U U U 
Facilitates bone 
growth U U U F F U F F F F 
No foreign body 
reaction F U U F F U U U U U 
Adequate 
mechanical 
properties 
FF F F F FF U F F U F 
No second operative 
site FF FF FF FF FF FF FF FF FF FF 
No donor site 
morbodity FF FF FF FF FF FF FF FF FF FF 
Easy to harvest FF FF FF FF FF FF FF FF FF FF 
Easy to mold FF FF FF F U F F F F F 
Adequate in quantity FF FF FF FF FF FF FF FF FF FF 
Low resorption FF FF FF F FF UU F F UU U 
No risk of 
transmission of 
infectious agent 
FF FF FF FF FF FF FF FF FF FF 
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2.3.1. Autogenous grafts 
Autogenous tissues were one of the first materials used to reconstruct the internal orbit 
(Converse and Smith 1957, Kaye 1966) and are still in frequent use today (Lai et al. 
1998, Ellis and Tan 2003). They require a second operative site, which increasing 
patient morbidity and require a greater operative time to harvest. Some of them are 
limited in quantity, and are plagued by variable amounts of resorption over time 
(Sullivan et al. 1993). Unpredictable resorption and the potential for late occurring 
enophthalmos are the most critical arguments against autogenous materials. This 
particularly concerns autogenous bone grafts and, to a lesser degree, cartilage. 
Autogenous cartilage grafts are also too flexible to provide adequate support for orbital 
contents in larger defects (Antonyshyn et al. 1989). Ilankovan and Jackson (1992) 
reported that cartilage in its fresh state has a tendency to warp and is unsatisfactory for 
reconstruction of bony orbital walls. 
 
2.3.1.1. Autogenous bone 
Autogenous bone grafting has been the gold standard in providing a framework for 
repair of injured facial skeleton and orbital walls (Kaye 1966, Rubin et al. 1992, Marx 
1994, Ellis and Tan 2003). The advantages of autogenous bone are its relatively good 
resistance to infection, its replacement by host bone in creeping substitution, the lack of 
a host response against the graft, and the lack of concern for late extrusion. Resorption 
and reduction of graft volume is obviously a concern for long-term success (Sullivan et 
al. 1993).  
Basically there are two forms of nonvascularized autogenous bone grafts: cortical and 
cancellous (Bonutti et al. 1998). Cancellous grafts are revascularized more rapidly and 
more completely than cortical grafts. The creeping substitution of a cancellous graft 
initially involves appositional bone formation followed by a resorptive phase, but with 
cortical grafts it is vice versa (Buchardt 1983). Furthermore, cancellous grafts tend to 
repair completely whereas cortical grafts remain an admixture of necrotic and viable 
bone (Buchardt 1983). Cortical grafts are able to withstand mechanical forces earlier 
than cancellous ones and are useful for filling defects where early mechanical loading is 
required (Buchardt 1983). Cancellous bone imparts little mechanical strength. When 
cancellous bone is used to reconstruct large continuity defects, additional stabilization 
and rigid fixation such as a titanium mesh system are required (Tideman et al. 1998). 
The combination – a corticocancellous graft - usually produces the best results by 
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combining the attributes of both graft forms (De Koomen et al. 1979, Egbert et al. 
1986). 
Different sources such as calvarium, iliac crest, mandibular and maxillary bone, and 
ribs have been used (Lee et al. 1998, Mintz et al. 1998, Dempf et al. 2001, Siddique 
and Mathog 2002, Ellis and Tan 2003). At the present, calvarium bone seems to be the 
material of choice for orbital wall reconstruction (Dempf et al. 2001, Ellis and Tan 
2003). Although there are multiple donor sites for autogenous grafts, the anterior iliac 
crest is the most common (St John et al. 2003). 
Autogenous bone graft from the anterior iliac crest is a favourable reconstruction 
material because enough bone is always available and bone can be harvested 
simultaneously with the orbital exploration. However, an iliac crest bone graft is said to 
be bulky unless trimmed and it may resorb unpredictably. Both de Visscher and van der 
Wal (1988) and Bartkowski and Krzystkowa (1982) used iliac crest graft for orbital 
floor or medial wall reconstruction in their follow-up studies and concluded that 
autogenous corticocancellous bone like iliac crest is very well tolerated and is an 
adequate material for orbital wall reconstruction. Their results are similar to those of 
many other researchers (Roncevic and Malinger 1981, Sullivan et al. 1993, Dempf et 
al. 2001, Ellis and Tan 2003). Donor site disadvantages of autogenous iliac bone graft 
include nerve and blood vessel injuries, chronic pain, gait disturbances and cosmetic 
nuisance. In the light of the high numbers of autologous iliac crest grafts used, the 
donor site morbidity seems to be low (Banwart et al. 1995, Ahlmann et al. 2002).   
 
2.3.2. Allogeneic grafts 
An allogeneic graft is a living or preserved tissue of one individual transferred to 
another of the same species but with a different genotype. In the literature, allogeneic 
implants are also referred to as allografts or homografts. Isograft or isogeneic graft 
refers to a tissue graft transplanted from one individual to another, who is genetically 
identical. Allogeneic material may include allogeneic bone, cartilage, dura and fascia. 
These materials contain no living cells and become incorporated into host tissues by 
providing a structural framework for ingrowth of host tissues. They do not require a 
second operative site and are generally abundant in supply. Allogeneic materials have 
been successfully used for orbital wall reconstruction.  However, the use of allogeneic 
grafts is decreasing because of concern over the antigenicity of the material and the 
potential transmission of infectious diseases (Burchardt 1983, Thadani et al. 1988).  
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2.3.3. Xenografts 
A xenograft is non-vital tissue that is harvested from one species and transferred to the 
recipient site of another species. Both soft tissue and bone grafts are available.  
Xenogeneic bone was popular in the 1960's but fell into disfavour due to reports of 
patients developing autoimmune diseases following bovine bone transplants (Pieron et 
al. 1968, Buchardt 1983). In theory, the transmission of infectious diseases is possible 
when xenografts are used, although no such reports seem to be available in the 
literature.   
Xenografts are rarely used for the repair of internal orbital fractures. Only a few case 
reports are available in the literature regarding their application within the orbit. A 
severe inflammatory reaction with the granulomatous component has been reported 
after the use of porcine dermis in orbital wall reconstruction (Converse et al. 1967, 
Webster 1988, Morax et al. 1993, Cheung et al. 2004). 
 
2.3.4. Alloplastic materials 
Alloplasts have gained popularity for reconstruction of the internal orbit because of 
their ease of use and the fact that there is no donor-site morbidity. Other benefits of 
alloplasts include shorter operation times, the large variety of sizes and shapes 
available, and their seemingly endless supply.  
 
2.3.4.1. Nonresorbable  
Nonresorbable alloplastic materials include: titanium, silicone, polytetrafluoroethylene, 
polyethylene, hydroxyapatite and bioactive glass. 
 
Titanium 
Titanium plates are thin, stiff and easy to contour. They are easily stabilized, maintain 
their shape, and have the unique ability to compensate for volume without the potential 
for resorption. When titanium plates were introduced, it was generally believed that 
they needed no removal, since titanium is a highly biocompatible material (Breme et al. 
1988). However, it has been shown that both titanium and aluminium are released from 
titanium implants into the adjacent structures and even into regional lymph nodes 
(Moberg et al. 1989, Onodera et al. 1993, Katou et al. 1996). The clinical relevance of 
this release is not yet known. It has been suggested that in paediatric surgery in the 
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areas of bony resorption and deposition, metallic fixation plates should be removed due 
to plate displacement and to restriction of growth (Fearon et al. 1995). 
There are further disadvantages with titanium implants in orbital wall reconstruction. 
These include the risk of extrusion due to dehiscence of covering soft tissue and the risk 
of infection. There is also a theoretical risk of injury to the tissues of the orbital apex 
from any subsequent blow to the orbit. Because of the mesh structure, the orbital 
implant is difficult to remove (Sugar et al. 1992).  
Titanium implants have been used to span large defects in the internal orbit to provide a 
platform for bone graft support. This technique proved to be reliable and bone graft 
positioning was more secure. The infection rate was reported to be 5% (Glassman et al. 
1990). It was not until the report by Sargent and Fulks (1991) that metals alone were 
routinely used for orbital reconstruction without an intervening bone graft or alloplast 
between the metal and the orbital soft tissues. Many researchers have concluded that 
titanium mesh implants are a simple and reliable option for routine orbital floor repair 
(Sugar et al. 1992, Mackenzie et al. 1999, Ellis and Tan 2003). 
Rubin and coworkers (1992) compared the use of custom-shaped orbital floor titanium 
plates or vitallium mesh with autogenous bone grafts. They reported no significant 
complications related to the orbital implants. Metal implants were easier to use than 
autogenous bone grafts. 
 
Silicone, polytetrafluoroethylene and polyethylene 
Silicon (Si) is the second most abundant element on earth, comprising around 28% of 
all matter. Silicones (polyorganosiloxanes) are synthetic polymers of silicon and 
oxygen (known as siloxane) modified with various organic groups attached to the 
silicon atoms. These organic molecules prevent the formation of the three-dimensional 
network characteristic of silica. Silicone rubber is a chemically inert material available 
in block and sheet forms. Polytetrafluoroethylene (Teflon®) is a long-chain halogenated 
carbon polymer made by the polymerization of tetrafluoroethylene gas at high 
temperature and pressure. Both materials evoke a mild fibroblastic or inflammatory 
reaction (Lossing and Hansson 1993, Cashman et al. 2002, Ward et al. 2002, Reno et 
al. 2003). Both have been used for orbital wall reconstruction even though they are 
neither osteogenic nor osteoconductive nor osteoinductive. Widely varying 
complications have arisen from the use of these alloplastic implants, such as inferior 
eyelid swelling, pain, ocular dystopia and maxillary sinusitis, extrusions and local 
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infections (Aronowitz et al. 1986, Dufresne et al. 1988, Morrison et al. 1995, Pauzie et 
al. 1997, Rubin and Yaremchuk 1997). 
Solid polyethylene, the structural component of porous polyethylene, is a highly inert 
material. It is synthesized by the polymerization of ethylene. A porous polyethylene 
implant is a biocompatible material composed of high-density polyethylene 
microspheres sintered to create a framework of interconnected pores. Its porous 
character allows for rapid fibrovascular and soft tissue ingrowth and eventual 
incorporation of bone. 
High-density porous polyethylene (HDPP) has been used extensively for craniofacial 
reconstructive procedures. HDPP implants have been used successfully for correction 
of mild to moderate posttraumatic enophthalmos (Karesh and Horswell 1996). In a 
series of 140 patients, there was just one instance of implant infection requiring 
removal, and no implant migration or exposure (Romano et al. 1993). Other 
investigators too, have concluded that porous polyethylene sheets offer advantages 
when used for orbital reconstruction. They seem to permit predictable, stable results 
with few complications (Rubin et al. 1994). 
 
Hydroxyapatite 
Hydroxyapatite (HA) can be manufactured from natural reef-building coral skeleton by 
a hydrothermal exchange reaction, where the trabecular, bone imitating structure of the 
coral remains unchanged but the calcium carbonate (CC) skeleton is converted to 
calcium phosphate, the main inorganic salt of bone (Roy and Linnehan 1974). HA has 
been used for both primary and secondary reconstruction of the orbital walls. Both HA 
block scaffolding and computer-aided machined HA ceramic implants have proved to 
be useful alternatives to metallic floor implants and autologous bone grafts in the 
reconstruction of large traumatic orbital floor defects (Hes and de Man 1990, Ono et al. 
1994, Lemke and Kikkawa 1999). 
 
Bioactive glass  
Bioactive glasses (BAGs) are silicates containing sodium, calcium, and phosphate as 
their main network modifier components. The glassy network of BAG binds to bone by 
a surface layer of hydroxyapatite that forms through chemical reaction with the glass. 
This chemical bonding of BAG and bone has been demonstrated by several 
investigators (Hench and Paschall 1973). It has proved to be biocompatible and 
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nontoxic (Wilson et al. 1981, Gross and Strunz 1985, Aitasalo et al. 2001). Bioactive 
glass is osteoconductive in humans (Schepers et al. 1993, Furusawa and Mizunuma 
1997, Tadjoedin et al. 2000). Studies have demonstrated that bioactive glass particles of 
narrow size range (300-355 µm [Biogran®]) have the capacity to stimulate bone tissue 
formation without contact with pre-existing bone (Huygh et al. 2002). 
Good results have been achieved with this material in frontal sinus surgery (Peltola et 
al. 1998). Only a few studies are available on the use of bioactive glass in orbital wall 
reconstruction. In a prospective study Kinnunen et al. (2000) compared the use of 
bioactive glass with conventional autogenous grafts (cartilage with or without 
lyophilized dura) for the repair of orbital floor defects after trauma. They concluded 
that bioactive glass was well tolerated and showed adequate maintenance of orbital and 
maxillary sinus volume without any evidence of resorption in either group. 
 
2.3.4.2. Resorbable  
Biodegradable polymers (Figure 3) have been used for biomedical applications for 
many years. Polyglycolide, polylactide, and polydioxanone all degrade in vitro and in 
vivo by hydrolysis. Enzymatic activity enhances the hydrolysis, degradation being more 
rapid in tissue environment than in vitro (Williams 1982).  
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Figure 3.  
PGA and PLA are synthesized by ring opening polymerization of the cyclic diesters of glycolic 
acid and lactic acid respectively. PDS is a high molecular weight crystalline polyester of para-
dioxanone. 
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Polydioxanone (PDS) 
PDS is a biodegradable material that loses 50% of its strength in the first postoperative 
month (Merten and Luhr 1994). It is a high molecular weight, colourless crystalline 
polyester of para-dioxanone. The glasstransition temperature of PDS is -16° C. At this 
temperature the material becomes brittle and rigid. Its melting point is 110o C (Doddi et 
al. 1977). At room temperature PDS is rubber-like and ductile.  
The degradation products of PDS are excreted mainly in the urine, but some are 
excreted in the feces and exhaled as CO2 (Ray et al. 1981). In vivo experiments on rats 
showed a slight tissue reaction (Knoop et al. 1987). PDS is completely absorbed after 6 
months (Hidding et al. 1991). PDS has been mainly used in sutures, cords, pins, and 
screws in experimental and clinical orthopaedic surgery (Claes et al. 1986, Mäkelä et 
al. 1989, Riedl and Genelin 1991, Plaga et al. 1992). It is usable in soft tissue, tendon, 
and ligament surgery because of its flexibility (Vainionpää et al. 1989). PDS has been 
reported to be well tolerated by the body and does not give rise to clinically detectable 
inflammatory reactions (Knoop et al. 1987, Mäkelä et al. 1989).  
New bone formation has been noted when PDS has been used for orbital wall 
reconstruction (Cantaloube et al. 1989). PDS seems to be easy to cut to suitable sizes 
and retains its structural integrity long enough for a sufficiently rigid scar to be formed 
(Cantaloube et al. 1989, Iizuka et al. 1991). Because of resorption of the thick plate, 
overcorrection was thought to be necessary (Iizuka et al. 1991). Other studies 
corroborated earlier findings. PDS can be shaped and adjusted, is mechanically good 
enough for orbital reconstruction, and resorbs within one year. Overall results seem to 
be acceptable (Hidding et al. 1991, Jank et al. 2003). 
However, some studies have shown less favourable outcomes related to PDS. Lack of 
osteoconductive properties was documented by Baumann and coworkers (2002). These 
authors concluded that large defects in the orbital floor (more than 2.5 cm2) cannot be 
reconstructed with PDS sheet, which should be used only in cases without massive 
orbital fat herniation. Merten and Luhr (1994) and later de Roche and coworkers (2001) 
agreed with these results and further showed that PDS provokes adverse foreign body 
reactions. PDS orbital implants are not available in the United States. 
 
Polylactide (PLA) and polyglycolide (PGA) 
PLA is a pale-coloured, semicrystalline polymer with a glasstransition temperature of 
57° C and a melting point of 174° C (Vert et al. 1981, Törmälä et al. 1998), (Figure 3). 
 
 
 24
PLA can exist in four forms, depending on the L – and D – configuration (Holten 
1971). If the polymer consists only of the L isomer, it is called poly-L-lactide acid, 
PLLA, which has most commonly been used for orthopaedic implants. If it contains 
both isomers, it is a stereocopolymer, called poly-D/L-lactide acid, often referred to as 
P-L/DL-LA or PLDLA. PLDLA is more amorphous and less crystalline and thus 
degrades faster than pure PLLA (Kulkarni et al. 1971).  
PLLA implants have been used for orbital floor reconstruction since 1972, when 
Cutright and Hunsuck (1972) published an experimental study on rhesus monkeys using 
1.5 mm thick PLLA sheets. They reported normal healing of the fracture and normal 
globe movements. The PLLA sheets were resorbed by phagocytes and giant cells with 
villous projections. Residual PLLA was detectable after 38 weeks. No inflammatory 
reactions were seen. Similar findings were reported later by Rozema and coworkers 
(1990). In a study by Cordewener and coworkers. (1996) the long-term outcome was 
evaluated after the repair of orbital floor defects in patients with resorbable as-
polymerized PLLA implants in order to determine whether these patients showed 
symptoms that could be indicative of the presence of a late tissue response. In the 
preceding years none of the patients had experienced any problems such as infection, 
migration, or extrusion of the implants, all of which might have indicated 
complications. The main drawback of PLLA implants, however, is its low degradation 
rate and slow resorption in clinical use (Bergsma et al. 1993, Tams et al. 1996, 
Suuronen et al. 1998). 
P-L/DL-LA implants have been used in an experimental study in rats. There were no 
signs of inflammation. The histological image of P-L/DL-LA 96/4 after 55 weeks 
closely resembled the image observed for PLLA in rats after 143 weeks. Because of the 
relative loss of mechanical properties osteosynthesis made with P-L/DL-LA 96/4 may 
be suitable only for applications under low biomechanical load (Cordewener et al. 
1995). Self-reinforced (SR) P-L/DL-LA plates and screws have been used clinically in 
orthognathic and trauma surgery. The short-term follow-up has been comparable to the 
“gold standard” of titanium plates and screws (Haers and Sailer 1998, Ylikontiola 
2004). No clinical foreign-body reactions caused by SR P-L/DL-LA devices have been 
reported (Suuronen 1993). 
PGA is a hard crystalline polymer which, when possessing fibrous properties, has a 
molecular weight from 20000 to 145000 (Frazza and Schmitt 1971). SR PGA implants 
were used to treat 20 blowout fractures (Sasserath et al. 1991). Two patients 
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complained of continuous infraorbital oedema, which, according to the authors, was 
caused by poor residual drainage. The problem was solved by regular massage of the 
region. 
Copolymers of biodegradable polyglycolide and polylactide acids have been used for 
fracture treatment. Experimental studies have shown that this copolymer has a more 
rapid rate of degradation (9 to 15 months) than PLLA and therefore might be more 
suitable as an orbital implant material (Bahr et al. 1999, Wiltfang et al. 1999). Clinical 
studies have shown good results with Lactosorb® throughout the craniofacial skeleton 
(Ahn et al. 1997, Enislidis et al. 1997). 
 
2.4. Tissue repair 
2.4.1. Osteogenesis, osteoinduction, osteoconduction 
Blowout fracture refers to a state where the walls of the orbit have fragmented, leading 
to a bone defect (Pfeiffer 1943). The aim of modern reconstruction should be to 
facilitate new bone formation over the defect area. New bone formation occurs via 
three biological mechanisms: osteogenesis, osteoinduction and osteoconduction. The 
implant used for blowout fracture repair should promote one or more of the above 
mechanisms leading to defect repair.  
Osteoblasts of the transplanted bone graft and of fractured bone are responsible for new 
bone formation, i.e. osteogenesis. Osteoblasts survive for up to five days post-
transplantation due to their ability to absorb nutrients from the surrounding tissues 
(Caplan 1994).  The mineralized matrix of cortical bone is relatively impervious and 
nutrition by diffusion alone will predominantly affect those cells at or near the surface 
of the graft in contact with the host tissue. Therefore, cells of the periosteum and 
endosteum at the edges of cortical bone grafts survive (Motoki and Mulliken 1990). 
Entrapped platelets inside the graft release potent growth factors (Caplan 1994) and 
endothelial cells initiate capillary ingrowth. Stem cells start to differentiate into 
osteoblasts, which together with endosteal osteoblasts from the transplanted bone start 
to lay down osteoid (Marx 1994). 
Osteoinduction is the formation of bone by connective tissue cells transformed into 
osteocompetent cells by inductive agents, usually proteins such as bone morphogenetic 
protein. Urist (2002) was the first to describe the osteoinduction mechanism in 1965. 
Since then, a wide variety of entities having different effects on bone have been 
discovered. They are classified as osteoinducers, osteopromoters or bioactive peptides. 
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Human bone morphogenetic proteins as an aid for fracture treatment have been 
successfully used in Finland (Govender et al. 2002). 
Osteoconduction describes bone formation by the process of ingrowth of capillaries 
and osteoprogenitor cells from the recipient bed into, around and through a graft or 
implant which acts as a scaffold for new bone formation. Unlike osteoinduction, this 
process occurs in an environment already containing bone.  
 
2.4.2. Wound healing  
Wound healing involves many complicated, concurrent events and can be divided into 
three overlapping phases: an inflammation phase, a granulation tissue formation phase, 
and a matrix formation/ remodelling phase. Interactions of the individual components 
of extracellular matrix (ECM) with specific cell surface molecules initiate a cascade of 
signal transduction. These transductions lead to varied cellular responses (Raghow 
1994).  
During the first stage (day 1 – day 3), neutrophils and monocytes appear in the wound 
space and mediators are released that then set the stage for the formation of granulation 
tissue (Gailit and Clark 1994). The second phase (day 4 – day 6) of wound healing is 
characterized by granulation tissue formation. The processes of angiogenesis, re-
epithelialization, and collagen synthesis occur. Important in granulation tissue 
formation is the development of an ECM (Gailit and Clark 1994). Remodelling is the 
third phase of wound healing (day 7 – ). ECM is revamped and the collagen is 
converted from type III collagen to type 1 collagen. As remodelling proceeds, 
fibronectin disappears from the wound and is replaced by collagen.  A gradual loss of 
cells and vasculature is detected during this phase (Raghow 1994). Also during this 
stage wound contraction occurs. A delicate balance in the biosynthetic and degradative 
pathways of ECM restructuring may swing this pendulum towards tissue remodelling 
or fibrosis. 
The wound contraction phenomenon is generally attributed to myofibroblasts, which 
are found in granulation tissue. This may last for several weeks (Ehrlich 1988). During 
the wound healing process, these cells produce tenascins and cellular fibronectin, both 
of which provide trophic support in the connective tissue (Mackie et al. 1988, Whitby 
and Ferguson 1991). 
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Tenascins (Tn) and Fibronectin (Fn) 
Tenascins are members of a large ECM glycoprotein family. The vertebrate tenascin 
family consists of at least three and possibly four member proteins, built up by the 
structural domains typical of the tenascins (Chiquet-Ehrismann et al. 1994). The 
functions of the tenascins are still largely unknown. Tiitta and coworkers (1992) have 
shown a prominent tenascin immunoreaction in inflammatory lesions. During wound 
healing, tenascins are present throughout the matrix of the granulation tissue, which 
fills full-thickness wounds, but is not detectable in the scar after wound contraction is 
completed (Mackie et al. 1988). Luomanen and Virtanen (1993) studied the distribution 
of extracellular matrix tenascin in normal mucosa and during healing of scalpel-incised 
or excised and CO2 laser-wounded rat tongue dorsal mucosa. According to their study 
the immunoreactivity to tenascin diminishes to almost normal 11 days after the 
operation. The overall tenascin staining is greatly increased in the synovial membrane-
like interface tissue between implant and bone in aseptic loosened hip prosthesis 
compared with synovial membrane and fibrous capsule from primary total hip 
replacement operations (Konttinen et al. 1998). When the cellular and molecular 
compositions of fibrous capsules removed from around silicone breast implants were 
studied, a massive deposition of tenascin was observed adjacent to the implant surface 
(Dolores et al. 2004). 
Fibronectin is of key importance in wound healing and is involved in all its phases 
(Luomanen and Virtanen 1991, Whitby and Ferguson 1991). Fibronectin is chemotactic 
for fibroblasts and macrophages (Nagelschmidt et al. 1987). Fibronectin plays a major 
role in the second phase of wound healing. The scaffolding helps fibroblasts and 
epithelial cells migrate over and through the extracellular matrix. This temporary 
basement membrane allows for the phenotypic and mitogenic changes noted in these 
cells during wound healing (Luomanen and Virtanen 1991). Only a few studies are 
available about cellular fibronectin (cFn) expression in connective tissue capsules 
around implanted materials. Dolores and coworkers (2004) analyzed of the cellular and 
molecular compositions of fibrous capsules removed from around silicone breast 
implants with complications in patients at various times after primary surgery and 
observed massive deposition of fibronectin adjacent to the implant surface. 
When synovial membrane-like interface tissue after aseptic loosening of prosthetic 
components was compared with osteoarthritic synovial membranes, expression of 
fibronectin had a similar distribution pattern in both tissues (Konttinen et al. 2001). 
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2.4.3. Peri-implant connective tissue capsule 
The mechanisms controlling the formation of peri-implant connective tissue capsule 
and the reactive and adaptive changes in it are not known. The mechanism seems to be 
linked to the low-grade chronic inflammation caused by the foreign body reaction 
(Asplund 1984, Ksander and Vistnes 1985, Burkhardt 1988, Bagambisa et al. 1994, 
Santavirta et al. 1998). Operative trauma, implant instability and corrosion/friction are 
recognized as aetiological factors in the production of the soft-tissue capsule which is 
often present around metal implants (Linder and Lundskog 1975, Goodman 1994, 
Santavirta et al. 1999). It has been demonstrated that the surface texture of an implant is 
also an important variable in determining the soft tissue response to a material and 
fibrous capsule formation (Taylor and Gibbons 1983, van Mullem et al. 1990). The 
peri-implant fibrous capsule contains cells including myofibroblasts (Lossing and 
Hansson 1993). They are unique smooth muscle-like fibroblasts that contain 
cytoskeletal α-actin bundles. They seem to generate contractile forces that produce 
wound contraction and peri-implant capsule contracture (Welch et al. 1990, Lossing 
and Hansson 1993).  
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3. AIMS OF THE STUDY 
The materials used to repair orbital defects have been broadly categorised as autologous 
and alloplastic. Autologous materials are generally biodegradable, while alloplastic 
materials are subdivided into biodegradable and non-biodegradable materials. The main 
aim of the present study was to investigate the clinical properties and biocompatability 
of orbital reconstruction materials and to produce recommendations for selection of 
these materials for routine clinical use. 
 
The specific objectives were: 
1. To study the mechanical properties of PDS sheets and to assess whether 
they provide adequate support for orbital contents in clinical use in order 
to prevent posttraumatic enophthalmos and hypo-ophthalmos. 
 
2. To study whether the mechanical properties of SR PLDLA 85/15, SR 
PLDLA 96/4 and SR PLDLA 96/70 composite implants are appropriate 
for orbital wall fracture reconstruction.  
 
3. To study  the distributions of Tn, cFn, α-actin and type I and type III 
collagen in the connective tissue capsule of PDS, SR PLDLA 85/15, SR 
PLDLA 96/4 and SR PLDLA 96/70 composite implants, and to study host 
response to these materials to assess their biocompatibility in possible 
clinical use 
 
4. To study whether autologous iliac bone graft restores the shape and 
volume of a fractured orbit, provides adequate support for orbital contents 
and facilitates new bone growth across the orbital wall defect to restore the 
orbital volume and to prevent posttraumatic enophthalmos and hypo-
ophthalmos.   
 
5. To develop a three-dimensional finite element model of the human orbit 
and to use it to study the stresses and strains required to produce traumatic 
orbital fractures and deformations. 
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4. MATERIALS AND METHODS 
Essential data, materials and follow-up times used in these experimental and clinical 
studies is given in Table 3.  
Table 3. 
Materials, follow-up times and properties of implants used in experimental and clinical studies. 
Roman numerals refer to the number of the original publication. 
Study 
 
Rabbit (I) Sheep (III) 
Number of animals / implants 10 / 60 18 / 18 
Implant placement Dorsal subcutis Orbital floor 
Follow-up 4, 12, 16, 36 and 48 weeks 12 , 16, 22 and 36 weeks 
Material SR poly-L/D-lactide acid 
stereocopolymer 
SR poly-L/D-lactide acid 
stereocopolymer 
Structure plate 
(SR PLDLA 85/15) 
plate 
(SR PLDLA 96/4) 
Molar ratio  85/15 96/4, low monomeric <0,16%  
Manufacturer Institute of Biomaterials, 
Tampere University of 
Technology, Finland 
Institute of Biomaterials, 
Tampere University of 
Technology, Finland 
Raw material Purac biochem Purac biochem 
Sterilization Ethylene oxide or gamma 
irradiation 
Gamma irradiation 
 
 
 
Study 
 
Rat (VI) Rat (VI) 
Number of animals / implants 12 / 12 12 / 12 
Implant placement Dorsal subcutis Dorsal subcutis 
Follow-up 2, 3, 4 and 5 months 3, 4, 5 and 7 months 
Material PDS®  SR poly-L/D-lactide acid 
stereocopolymer  
mesh sheet 
SR poly-L/DL-lactide acid 
stereocopolymer  
frame 
Structure folio Combined mesh sheet and frame, plate 
(SR PLDLA 96/70) 
Molar ratio   96/4 70/30 
Manufacturer Ethicon, Nordenstedt, 
Germany 
Institute of Biomaterials, 
Tampere University of 
Technology, Finland 
Institute of Biomaterials, 
Tampere University of 
Technology, Finland 
Raw material  Purac Biochem b.v.  
Netherlands 
Boehring Ingelheim,  
Germany 
Sterilization Gamma irradiation Gamma irradiation Gamma irradiation 
 
 
 
Study 
 
Human (II) Human (IV) 
Number of patients / implants 16 / 16 24 / 24 
Implant placement Orbital floor Orbital floor 
Follow-up 1, 2, 4, 8, 12, 36 weeks 1, 2, 4, 8, 16 and 36 weeks 
Material PDS® Iliac crest graft 
Structure Folio Corticocancellous free graft 
Manufacturer Ethicon, Johnson&Johnson, 
Brussels, Belgium 
Autogenous 
Sterilization Gamma irradiation  
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4.1. Experimental studies (I, III, VI) 
The experimental studies included three different implant models with four types of 
implants using rabbit (I), sheep (III) and rat (VI) as research animals. For 
methodological details see the original publications. The mechanical properties of 
polydioxanone (PDS®) orbital wall implant and three types of poly-L/D-lactide 
implants were evaluated and compared. Immunohistochemistry, microscopy and 
electron microscopy studies were performed. 
 
4.1.1. Animals, anaesthesia, follow-ups 
Experimental study using rabbits (I) 
Ten rabbits were anaesthetized with subcutaneous (s.c.) ketamine (Ketalar®, Parke- 
Davis, Barcelona, Spain) 25 mg/kg and medetomiden (Domitor®, Lääke-Farmos, 
Turku, Finland) 0.3 mg/kg. Two animals were sacrificed at each follow-up time.  
 
Experimental study using sheep (III) 
Anaesthesia for the 18 sheep used in these experiments was induced using Propofol 2 
mg/kg (Rapifen, Zeneca Ltd., Cheshire, UK) and maintained with 2-2.5% halothane in 
oxygen using an open ventilation system following intubation. At each follow-up 
respectively 5, 4, 4 and 5 animals were sacrificed. 
 
Experimental study using rats (VI) 
24 adult male E.DA/KS:Fi rats were anaesthesized using a fentanyl-fluonison 
combination (1,5 ml/kg s.c., Janssen-Cilag, Sanderton, U; Hofmann La Roche, Basle, 
Switzerland). Three animals were sacrificed at each follow-up 
 
4.1.2. Operative techniques 
Experimental study using the rabbit model (I) 
SR PLDLA 85/15 plates were inserted into the dorsal subcutaneous tissue. The two 
control rabbits were operated on in the same manner but without implantation. After the 
follow-up the plates and surrounding connective tissues were carefully removed. In the 
control animals the scar and connective tissue were removed from the operated region. 
Connective tissue capsules enveloping the plates were examined using haematoxylin-
eosin staining and immunohistochemistry. The mechanical properties of the implants 
were analyzed. 
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Experimental study using the sheep model (III) 
Both orbital floors were exposed using an infraorbital approach. The periosteum was 
elevated and the floor was cut open with a burr and chisel. The defects created were 10 
mm x 20 mm in size. The orbital content was repositioned and the floor was 
reconstructed using a PLDLA 96/4 plate. The implant was fixed to the orbital floor with 
two micro tacks. No reconstruction was performed in the contralateral orbital floor. 
After the follow-up the orbital floors were exposed. The floors were photographed and 
measured. Implants were removed for further mechanical analyses together with tissue 
samples from the superior surface of the connective tissue capsule for 
immunohistochemical studies. 
 
Experimental study using the rat model (VI) 
Either an SR PLDLA 96/70 composite plate or PDS folio was placed in the dorsal 
subcutaneous tissue of each animal. At the end of each follow-up a full thickness of 
dorsal skin containing the implant and the surrounding capsule was excised from each 
animal. Connective tissue capsules enveloping the plates were removed for 
immunohistochemistry. The mechanical properties of the implants were analyzed.
 
4.1.3. Implants 
Experimental study using the rabbit model (I) 
The implants were manufactured from poly-L/D-lactide acid stereocopolymer 85/15 
(SR PLDLA 85/15), (Table 3). The self-reinforcing technique was used. The polymer 
was melt extruded at 135°C into circular rods of diameter 5 mm using an Axon BX-15 
extruder (Axon, Sweden) and subsequently drawn at 90°C through a heated conical die 
to a draw ratio of 2.5. The drawn rods (diameter 3.8 mm and length 60 mm) were 
compressed between flat metal surfaces at 115°C using a 100 kN compression force to 
produce plates of thickness 0.3 mm. The plates were cut to a width of 12 mm and to a 
length of 50 mm. The mid-portion was perforated. The plates were then divided into 
two groups and sterilized either with gamma irradiation (2.5 MRad dose, g.i.) or with 
gas (ethylene oxide, e.o.). 
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Experimental study using the sheep model (III) 
The implants were manufactured from low monomeric poly-L/D-lactide acid 
stereocopolymer 96/4 (SR PLDLA 96/4), (Table 3). The self-reinforcing technique was 
used. The polymer was melt extruded into continuous plates of thickness 0.45 mm ± 
0.05 mm and width 80 mm using an Axon BX15 extruder (Axon, Sweden) equipped 
with a flat film die and an Axon BDB take-off machine. The SR PLDLA 96/4 plates 
were allowed to cool at room temperature (20oC). After cooling the plates were 
reheated to 70°C and biaxially stretched into the shape of a bowl over a hemispherical 
steel die with a radius of 35 mm. After cooling, implants of diameter 28 mm were cut. 
Micro tacks were manufactured using a self-reinforcing technique (SR) from the same 
poly-L/D-lactide acid stereocopolymer as the plates, at the Institute of Biomaterials, 
Tampere University of Technology, Tampere, Finland. Tacks, 5 mm long with a shaft 
of diameter 1.1 mm and a head of diameter 3.1 mm, were produced. 
 
Experimental study using the rat model (IV) 
The materials used were standard 0.25 mm x 30 mm x 40 mm orbital floor 
polydioxanone (PDS®) folio and a similarly shaped SR poly-L/DL-lactide copolymer 
composite implant (Table 3). P(L/DL)LA 70/30 (PLA70, i.v. 5.7 dl/g, Boehringer 
Ingelheim, Germany) was melt-extruded to thin, rigid plates (nominal thickness 0.3 – 
0.4 mm). P(L/D)LA 96/4 (PLA96, i.v. 6.83 dl/g, Purac biochem b.v. Holland) was 
melt-spun to 4-ply multifilaments to a draw ratio 4.3.  
Each SR PLDLA 96/70 consisted a mesh sheet (SR P(L/D)LA 96/4) compressed onto 
copolymer frame (SR P(L/DL)LA 70/30), (Figure 4). The self-reinforcing technique 
was used. Dimensions of the central area were 20 mm x 10 mm x 0.5 mm and the outer 
dimensions were 30 mm x 22 mm x 0.5 mm.  
 
 
 
Figure 4. 
Rat model: the shape of the SR PLDLA 
96/70 implant was oval and composed of  a 
mesh sheet centre within a solid frame. 
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4.1.4. Macroscopic evaluation and radiographics 
Experimental study using the sheep model (III) 
The macroscopic outcome of orbital floor reconstruction was evaluated by measuring 
both the largest residual bone defect and the deepest depression of the orbital floor 
under the direct vision using a calliper ruler.  
The specimen was placed on a standard X-ray unit plate and fixed to the chin rest 
(Scanora, Soredex, Orion Corp., Helsinki, Finland) with the orbital floor horizontal. 
Narrow beam linear scanning (60 kV, 4 mA, 16 s, magnification factor 1.2) and spiral 
(=multidirectional) tomography (60 kV, 1.6 mA, 4 x 20 s, magnification factor 1.2) 
with 4 mm cuts were used. For narrow beam linear scanning, each specimen was 
imaged separately. For tomography, left and right orbital specimens were placed side 
by side. 
Orbital depression was measured in both images of every specimen and expressed in 
mm (corrected by the magnification factor). New bone formation was evaluated by 
measuring the thickness of bone in the defect area. This is expressed in millimetres, 
measured perpendicular to the orbital floor. 
 
4.1.5. Material characterization 
Experimental study using the rabbit model (I) 
The changes in tensile strength and crystallinity, and changes in intrinsic viscosity 
(indicative of molecular weight) were determined.  
The tensile strengths of the intact plates and after in vivo exposure were measured using 
a Lloyd 6000R Materials Testing Machine (Lloyd Instruments PLC, Fareham, UK) at 
room temperature (22-23°C). The cross-head speed was 10 mm/min and the gauge 
length 20 mm.  
The degree of crystallinity was estimated from the heat of fusion, assuming 93.7 J/g 
calculated by Fischer and coworkers (1973) for 100% crystalline PLLA. Duplicate 
samples were used. A Perkin-Elmer DSC-7 differential scanning calorimeter (DSC, 
Perkin-Elmer Co., USA), calibrated with indium standards, was used to determine the 
heat of fusion of intact SR PLDLA 85/15 plates and after in vivo exposure. The DSC 
was operated at a heating rate of 20°C/min. Dry 6 ± 1 mg samples evacuated at room 
temperature for 3 days were used in each case. The samples were heated in a nitrogen 
atmosphere from room temperature to 200°C and the heat of fusion was estimated from 
the area enclosed by the DSC curve and the baseline.  
 
 
 35
The viscosity values (according to ASTM D 445-88) of the plates equivalent to the 
molecular weight of the polymer were measured in chloroform at 25°C with an 
Ubbelohde capillary viscometer. Inherent viscosities in a 0.1% (0.1 g/dl) solution were 
determined as an indication of molecular weight decrease during degradation (Pistner et 
al. 1993). Viscosity-average molecular weights (g/mol) were estimated using the Mark 
- Houwink equation (Gogolewsky et al. 1993). 
 
Experimental study using the sheep model (III) 
The shear strength of the plate was determined by shearing a 6 mm diameter hole 
through the plate using a punching tool assembly constructed to a modification of BS 
2782, method 340 A. The test was performed at 20°C in a Lloyd 6000R material testing 
machine (Lloyd lnstruments, PLC, UK) operating at a cross-head speed of 10 mm/min. 
Shear strength was calculated from the following equation: S = F/лDT (S =shear 
strength (MPa), F=force (N) at fracture, D=diameter (mm) of punch, T=mean thickness 
(mm) of plate). 
The degree for the crystallinity and the viscosity values were measured using the 
methods described for the rabbit model (I) above.  
 
Experimental study using the rat model (VI) 
Gel Permeation Chromatography (GPC) 
Each sample was weighed to 7.35 ± 0.15 mg. The mesh, the frame and PDS were 
analysed separately. 
The weight-average molecular weight (Mw) and polydispersity (PD) values of the 
samples were determined. PLDLA samples were dissolved in chloroform and incubated 
for 24 hours at 22°C. 5 µl of 6% dichlorobentzene was added to each sample to provide 
a reference peak. Two parallel samples were used. Two Mixed-C columns (Polymer 
Laboratories, MA, USA) and one primary column (Polymer Laboratories) were used. 
The GPC system consisted of Waters 410 RI (Waters, Milford, MA, USA) differential 
refractometer detector and a Waters 515 high-pressure liquid chromatography (HPLC) 
pump. Chloroform was both eluent and solvent. The injected sample concentration was 
0.1 mass-% and, the injection volume and eluent flow rates were 150 µl and 1 ml/min 
respectively. PDS samples were dissolved in chloroform and then incubated overnight 
at 45°C. Further procedures for PDS samples were as described above for the P-L/DL-
LA samples.  
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The analysis was carried out using Millenium 32 software.The mathematical definition 
of weight-average molecular weight (Mw) is shown by the following formula: 
 
 
where Ni is the number of molecules with molecular weight Mi.  
Polydispersity (PD) is the ratio of weight-average molecular weight to number-average 
molecular weight: 
 
 
where PD is polydispersity, and Mw is the weight-average molecular weight. PD 
indicates the width of the distribution. 
 
Differential Scanning Calorimetry (DSC) 
Each sample was weighed to 6 ± 0.1 mg. The frame (P(L/DL)LA 70/30), the mesh 
sheet (P(L/D)LA 96/4) and PDS were analysed separately.  
The glass transition temperature, melting temperature and crystallinity of the samples 
were determined using a Perkin Elmer Pyris 1 DSC Differential Scanning Calorimeter 
(Perkin Elmer Instruments, Norwalk, CT, USA). An automated sampler, Autosampler 
(Perkin Elmer Instruments), was used. The equipment was indium calibrated and results 
were calculated using the baseline. Experiments were performed in a nitrogen 
atmosphere. Each polylactide sample was heated from 27°C to 220°C at 20°C/min and 
then rapidly cooled to 27°C at 200°C/min before the heating cycle was repeated. Each 
PDS sample was heated from – 40°C to +140°C at 20°C/min and then rapidly cooled to 
– 40°C at 200°C/min before the heating cycle was repeated. 
The results were analysed using a Perkin Elmer Analyser program (Perkin Elmer 
Instruments, Norwalk, CT, USA). Tg was determined from the second heating cycle, 
i.e. after rapid cooling the extrapolated value provided by the analysis program was 
used. Tm and crystallinity were determined from the first heating cycle. The 
crystallinity of PDS was determined by assuming the initial value of crystallinity to be 
100. The values obtained for the following samples were then compared with this 
value. 
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4.1.6. Histology and immunohistochemistry 
Experimental study using the rabbit model (I) 
Indirect immunofluorescence was performed with cryosections of 5 µm thickness. The 
specimens were incubated in the primary antibodies for 30 min, tenascin (Howeedy et 
al. 1990) and cellular fibronectin (Vartio et al. 1987), (Table 4.) before addition of 
fluorescein isothiocyanate (FITC)-coupled sheep anti-mouse IgG antiserum (dilution 
1/120, Sigma, St Louis, MO, USA). The stained sections were coated with glycerine 
(dilution 3/1 with phosphate-buffered saline). The sections were examined in a Leica 
Aristoplan. 
The degree of immunofluorescence staining was evaluated by two observers 
independently using 100 - 200 x magnification by means of an arbitrary scale (– = no or 
slight reactivity, + = moderate or high reactivity).  
 
Table 4. 
Rabbit model. Antibodies used for immunohistochemistry 
1Sigma, St Louis, MO, USA 
Antigen Antibody Source Negative control 
Tn 100 EB2 I. Virtanen Normal mouse serum 
cFn 52 DH1 I. Virtanen Normal mouse serum 
α-actin Mouse monoclonal 
antibody 
Sigma1 Normal mouse serum 
 
Experimental study using the sheep model (III) 
Frozen sections 6 µm thick were used for hematoxylin and eosin staining and for 
APAAP immunohistochemistry (Dako A/S, Glostrup, Denmark). Sections were first 
incubated in primary antibodies for tenascin (Balza et al. 1993) and cellular fibronectin 
(Vartio et al. 1987), (Table 5.). Secondary antibody was applied for 30 minutes before 
counterstaining in Mayer dye. 
The degree of immunostaining was evaluated by two observers independently using 
40x magnification by means of an arbitrary scale (–  = no reactivity, + = moderate or 
high reactivity). Four consecutive visual fields (0.23 mm x 0.16 mm) were evaluated. 
 
Table 5. 
Sheep model. Antibodies used for immunohistochemistry  
Antigen Antibody Source Negative control 
Tn BC-2, BC-4 L. Zardi  Non-immune serum 
cFn 52 DH1 I. Virtanen Non-immune serum 
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Experimental study using the rat model (VI) 
Indirect immunofluorescence staining was performed on 5 µm thick cryosections. 
Sections were first incubated in primary antibodies for Tn-C (1:250) and α-actin 
(1:400) followed by fluorescence isothiocyanate (FITC)–conjugated sheep anti-mouse 
IgG (1:250) for Tn-C, rodamine-conjugated goat anti-rabbit (1:100) for α-actin and 
DAPI (1:200) for cell nucleus (Table 6). Sections were examined with a Leitz 
Aristoplan microscope (Leitz, Wetzlar, Germany) with an epi-illuminator and 
appropriate filters. 
T-lymphocyte marker CD2 and type I collagen were stained using an ARK™  manual 
Animal Research Kit (Dako, Glostrup, Denmark). The antibodies are listed in Table 6. 
Type III collagen was stained using a Vectastain® ABC manual Avidin-Biotin 
Peroxidase Complex method kit (Vector Laboratories Inc., CA, USA). During type III 
collagen staining, sections were incubated with a collagenase C6885 (Sigma, St. Louis, 
MO, USA) solution.  
Endogenous peroxidase-positive monocytes/macrophages were detected using 
endogenous peroxidase staining.  
Table 6. 
Rat model. Antibodies used for immunohistochemistry 
1Telios Pharmaceuticals, San Diego, CA, USA 
2Serotec Ltd.,Oxford, England 
3Chemicon International, Inc., CA, USA 
4Calbiochem-Novabiochem Corp., CA, USA 
Antigen Antibody Source Negative control 
Tn-C Rabbit polyclonal 
immunoglobulin 
Telios1 Non-immune serum 
α-actin Rabbit monoclonal 
antibody 
Telios1 Non-immune serum 
CD2 Mouse monoclonal 
IgG CD2 
Serotec2 Non-immune serum 
Collagen I Monoclonal 
collagen I antibody 
Chemicon3 Dako X 0931 
Collagen III Polyclonal 
immunoglobulin 
CN4 Dako X 0903 
 
 
4.1.6. Electron microscopy 
Experimental study using the rabbit model (III) 
Transmission electron microscopy (TEM) 
For electron microscopy, a small fragment of connective tissue was cut. These 
fragments were fixed in 2% glutaraldehyde in phosphate buffer (0.1 M, pH 7.4) for 60 
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minutes and postfixed in 1% osmium tetroxide in the same buffer. After dehydration, 
the specimens were embedded in Epon 812. Thin sections (1 µm) were cut and stained 
with methyl blue and studied under a stereomicroscope for orientation. Ultra-thin 
sections were then made of representative specimens stained with uranyl acetate and 
lead citrate and studied in a Jeol 1200EX transmission electron microscope (Jeol Ltd, 
Tokyo, Japan) operating at 60 kV accelerating voltage. 
 
Experimental study using the rat model (VI) 
Scanning electron microscopy (SEM) 
The implants comprising mesh sheet and the frame PLDLA 96/70 and PDS were cut 
with a surgical blade and glued with conductive graphite (Pelco ®  Conductive 
Graphite, Pelco International, Redding, CA, USA) onto a metal mount, dried for 2 
hours in a laminar flow hood and then overnight in vacuum at room temperature. The 
samples were coated with gold in an Edwards S 150 Sputter Coater (BOC Edwards, 
MA, USA) for 90 seconds twice at 20 mV in an argon atmosphere. The samples were 
analysed using a JEOL T100 scanning electron microscope (Jeol Ltd, Tokyo, Japan) at 
15 kV with SemAfore (Jeol Ltd.) analysing program. 
 
4.1.8.  Statistics 
Experimental study using the rat model (VI) 
The analysis of tenascin and α-actin reactivity was qualitative. An arbitrary scale, 0 = 
no or slight reactivity, 1 = moderate or high reactivity, was used. Stained sections were 
compared with control sections from which primary antibody had been omitted. 
The analysis of cell densities of T-cell and monocyte/macrophage was quantitative and 
was performed using a stage micrometer (Graticules Ltd, Tonbridge, Kent, England). 
The area of each rectangle was of 0.0368 mm2 (dimensions: 0.23 x 0.16 mm2). The 
number of positively stained cells in four parallel rectangular areas was counted for all 
animals, from the implant surface towards the dense connective tissue. The cell density 
(cells / mm2) was calculated by dividing the average number (N=3) of detected cells 
with area examined. 
Type I and type III collagens were quantified using a 10 x 10 ocular grid (Zeiss, 
Esslingen, Germany). Five random ocular grid areas from each zone (inner layer / outer 
layer) in all samples (N=3) were analyzed. Positively stained squares were calculated 
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and the results were given as the percentage of positive squares per 100 squares (10 x10 
grids). The results are presented as an average (N=3). 
Statistical differences between T-cell and monocyte/macrophage densities (PDS vs. SR 
PLDLA 96/70) and between collagen I and III positivities (PDS vs. SR PLDLA 96/70 
and inner vs. outer layer) were tested using student’s t-test. The data tested was 
normally distributed.  
The statistical differences between T-cell and monocyte/macrophage densities and type 
I and III collagen positivities as a function of time were tested using the nonparametric 
Kruskall-Wallis test.  
Statistical tests were performed using GraphPad Prism ® software (GraphPad Software, 
Inc. 5755 Oberlin Drive, #110 • San Diego, CA 92121 USA). 
 
4.2. Clinical studies (II, IV) 
Clinical studies included two different models, one using bone graft (IV) and the other 
polydioxanone (PDS®) folio (II) as implant material. Twenty-four consecutive orbital 
blowout fractures were reconstructed using autogenous iliac bone grafts and 16 
consecutive orbital blowout fractures using PDS® folio (Ethicon, Johnson & Johnson, 
Brussels, Belgium). This study was approved by the local ethical committee.  
 
4.2.1.  Implants  
The free bone graft was harvested from the medial wall of the anterior ileum and 
trimmed with a drill bit to cover the defect being measured. The thickness of the graft 
was thinned down to 1 mm in the periphery and to 2-3 mm in the central area. 
PDS implants of two different shapes and sizes were used. They were either kidney 
shaped folios of 40 mm x 30 mm x 0.25 mm or round plates of 28 mm x 1 mm. The 
former were used in six patients and the latter in nine. One patient was treated with 
both.  
 
4.2.2. Operative techniques 
The orbit was explored by approach through subciliary or lower eyelid. The periost was 
sharply incised at the infraorbital rim and the fracture area was exposed. The prolapsed 
orbital content was repositioned. The orbital floor was reconstructed using either a 
subperiosteally placed iliac crest graft or a PDS implant.  
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4.2.3. Clinical examinations 
The study protocol consisted of clinical examinations preoperatively and at 1, 2, 4, 8, 
16, 36  (bone graft) and at 1, 2, 4, 8, 12, 36  (PDS) weeks postoperatively. During each 
follow-up, eye movements in nine directions, enophthalmos and hypo-ophthalmus were 
assessed. The degree of horizontal displacement was measured using a Keeler 
exophthalmometer®. Vertical displacement was measured using an optician’s 
examination spectacles provided with a vertical scale calibrated in millimetres.  
 
4.2.4. Computed tomography and magnetic imaging  
CT and MRI imaging were performed preoperatively, and 2 weeks, 30 weeks (iliac 
crest graft) and 36 weeks (PDS) postoperatively.  
The CT examinations were performed using a Siemens Somatom CR CT scanner 
(Siemens, Erlangen, Germany) with 4 mm thick contiguous slices in the coronal and 
sagittal planes. The scan parameters were: voltage 125 kV, MAS 500, measuring time 7 
s, projections 720.  
MRI was performed using a Siemens Vision imager operating at 1.5 T (Siemens, 
Erlangen Germany). Coronal slices perpendicular to the optical nerves were obtained 
from both eyes with a T1-weighted spin-echo (SE) sequence 600/15/3 
(TR/TE/excitations). Coronal T2-weighted fat suppression sequence 1800/20/1/150 
(TR/TE/excitations/FA) of the fractured internal orbital wall was obtained in all 
patients. T1-weighted slices were 2 mm thick with a 0.2 mm interslice gap. T2-
weighted slices were 3 mm thick with a 0.3 mm interslice gap.  
The angle and position of the in situ iliac bone graft were assessed using CT imaging in 
the following manner: the angle was assessed by comparing the sagittal and coronal 
plane of the bone graft with that of the floor of the uninjured orbit. If the angle was 
identical it was graded good, otherwise poor. The craniocaudal height of the bone graft 
was measured at both anterior and posterior orbits using the uninjured orbital floor as 
the theoretical reference plane. The difference was measured in millimetres by 
comparing the position of the bone graft with the floor of the uninjured orbit; minus (-) 
stands for caudal and plus (+) for cranial direction. The state of resorption was assessed 
qualitatively and graded as follows: 0 = total, 1 = moderate, 2 = mild, and the state of 
bone growth: 0 = none, 1 = moderate, 2 = intense. 
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4.3. Finite element analysis (VI) 
Geometric modelling and material properties 
The bony orbit was approximated as a pyramid with the base serving as an opening for 
the eye and the apex directed towards the brain (Power 2001, Sauerland 1994). The 
height of the pyramid was approximately 50 mm, while the opening for the optic nerve 
was approximately 10 mm. The bone was simulated as an orthotropic material and its 
elastic properties were derived from past reports (Table 7). The model of the human eye 
was composed of a superficial layer formed by the cornea and sclera and inner layer 
formed by the lens, held in place by ciliary and vitreous bodies and aqueous humour. 
For simplicity, the cornea was assumed to be spherical, with a central thickness of 0.5 
mm and a central radius of curvature of 7.8 mm (Uchio et al. 2001, Uchio et al. 2003). 
The material properties of the several components of the eye are summarised in Table 7 
and taken from a study by Uchio and coworkers (2001). The lens was modelled as a 
rigid body, and the vitreous body as a solid mass with a hydrostatic pressure of 20 mm 
Hg (2.7 KPa). The cornea was loaded by the intra-ocular pressure on the posterior 
surface and by atmospheric pressure on the anterior surface. The loading produced by 
the eyelids was ignored (Kobayashi et al. 1971, Uchio et al. 2001). The finite element 
model was loaded using multiple force vectors to simulate muscle forces.  
Table 7. 
Summary of eye’s material properties. E: Young′s modulus of elasticity. ν: 
Poisson′s ratio. The first subscript is the direction of the primary strain, the 
second subscript is the direction of the secondary strain.  
STRUCTURE YOUNG′S 
MODULUS 
E (MPa) 
POISSON′S 
RATIO (ν) 
DENSITY 
(kg/m2) 
LITERATURE 
SOURCE 
Cornea Nonlinear  - 1400 Uchio 2001 
Sclera Nonlinear - 1400 Uchio 2001 
Extra/ocular 
muscles 
11.0 0.40 1600 Power 2001 
Ciliary body 11.0 0.40 1600 Power 2001 
Fatty tissue 0.047 0.49 999 Power 2001 
Vitreous body 0.042 0.49 999 Power 2001 
Aqueous body 0.037 0.49 999 Power 2001 
Lens - - 315 Power 2001 
Bone Ex = 19.5 
Ey = 13.6 
Ez = 10.2 
νxy = 0.39 
νyz = 0.20 
νxz = 0.55 
-  
Dechow et al. 1992 
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Finite element modelling (FEM) 
The geometric entities created in the previous step were mapped with finite elements 
and nodes. Mapping was performed with the semi-automatic option Finite Element 
Generation (FEG) available in Display III (NISA, EMRC, Troy, USA). The mesh 
volumes of the bony orbit, vitreous and fatty tissues were subdivided into brick-shaped 
(six sided with 24 degrees of freedom) and wedge-shaped (five sided with 18 degrees 
of freedom) solid linear elements. Triangular membrane elements were used to model 
the cornea and sclera. To maintain a proper geometrical aspect ratio, thin regions were 
subdivided into an extremely high number of elements. When the solid parabolic brick 
elements were used to model such a complex shape as that of the orbit, it has been 
noted that although more degrees of freedom would give better interpolated data, the 
mid-side nodes of the elements also allow for higher distortions to occur (Korioth and 
Versulis 1997, Al-Sukhun 2003). Thus, by selecting a higher number of less distorted 
solid linear brick elements, the orbit was expected to be satisfactorily modelled. The 
finite element model was checked for node coincidence and discontinuities (i.e. gaps 
between elements).  
A typical missile impact velocity of 30 m/s was used in this study. In view of the 
clinical data, the range of missile weight in this simulation was set at 0.5 ─ 1 kg. The 
impact was initially directed at right angles from the front to the orbital rim. The 
simulation was performed five times, with the direction of the missile impact varied by 
450 upward, downward, right and left. The finite element model was then used to 
predict the variables at each node position. These variables were: 
1. Stresses / Strains - in the form of maximum, minimum and shear stresses / strains 
2. Displacement - representation of motion of structures. 
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5. RESULTS 
5.1. Experimental studies (I, III, VI) 
5.1.1. Macroscopic findings  
Experimental study using the rabbit model (I) 
SR PLDLA 85/15 implants were broken already at week 4 (Figure 5). At week 48, 
macroscopic examination revealed that the gamma-sterilized implants had disappeared 
whereas the ethylene-oxide sterilized implants were seen as rounded masses.  
 
 
 
Figure 5. 
Rabbit model: SR PLDLA 85/15 implants 
were removed from the dorsal 
subcutaneuos tissue together with the 
surrounding connective tissue capsule. 
Note the fractured SR PLDLA 85/15 plate.  
 
Experimental study using the sheep model (III) 
At week 12, all five SR PLDLA 96/4 implants were considerably deformed and coiled 
(Figures 6 - 7) and enveloped in a thick and elastic connective tissue capsule. Originally 
pliable implants had become fragile. A residual defect in the bone was seen in 6 out of 
10 of the orbital floors, equally the reconstructed and control sides. All reconstructed 
orbital floors were mildly (5-7 mm) displaced into the maxillary sinus.  
At week 36, three implants were surrounded by a bony capsule. The shape of the 
implant was identical to the shape of the displaced (sunken) orbital floor. Two capsules 
contained fluid. Clinical examination of the specimen showed that fractured orbital 
floors had healed and bony union was achieved (Figures 8 A and B). However, the 
correct positions of the orbital floors were not achieved.  
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Figure 6. 
Sheep model: SR PLDLA 96/4 implants 
were identified and removed after 
separating the orbits from the skull. The 
implant capsule is elevated and is shown 
here by a needle. 
 
 
 
 
Figure 7. 
The SR PLDLA 96/4 implants were 
deformed after only 3 months without any 
macroscopic signs of degradation. 
 
 
 
Figure 8 A.  
After removal (9 months) of the SR 
PLDLA 96/4 implant bone growth over the 
defect area (arrows) was detected.  
 
 
 
Figure 8 B. 
On the control side a residual defect 
(arrow) was macroscopially visible in only 
one case. 
 
 
 
 46
Experimental study using the rat model (VI) 
Primary healing was good in all animals except one in the PDS group, which suffered 
superficial wound dehiscence. However, this healed well during the first week of 
observation. 
After two months the PDS folio had degraded into hard, sharp pieces inside the thick 
capsule (Figure 9.). After three months the PDS had degraded further, but no changes in 
the PLDLA 96/70 implants were apparent. After four months the PLDLA 96/70 
implants were about the same size as at the beginning but had acquired the shape of the 
dorsum. No further change in shape was observed. After five months the PDS implant 
had become a soft, round mass with a maximum diameter of 10 mm. 
 
 
 
Figure 9. 
Rat model: SR PLDLA 96/70 and PDS® 
implants were removed from the dorsal 
subcutaneus tissue with the surrounding 
connective capsule. The degrading PDS 
implant is encapsulated, the capsule is thick 
and clearly visible. 
 
 
5.1.2. Radiographic findings  
Experimental study using the sheep model (III) 
Coronal CT sections from the specimen showed that bone defects did not ossify during 
the study. The differences in the size and shape of the defect between the implant and 
control groups were not statistically significant. A discrepancy was seen between 
results of CT imaging and the results of the clinical observation (Figure 10). 
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Figure 10. 
The bone depressions and defects of reconstructed (SR PLDLA 96/4 implant) orbital floors 
measured by CT imaging and clinically, from both reconstructed (R), and non-reconstructed 
sites (non R). No statistical differences were found between the two groups. Note the 
discrepancy between clinical and CT results. Results are average values in mm.  
 
 
5.1.3. Strength and crystallinity findings 
Experimental study using the rabbit model (I) 
The SR PLDLA 85/15 implant was inadequate, as it had already broken by week 4. The 
initial tensile strength was 43.8 MPa for ethylene oxide-sterilized and 33.1 MPa for 
gamma-irradiated implants. Tensile strengths could not be measured because of the 
implants’ fragility. The initial mean Mv molecular weights for e.o. and g.i. implants 
were subsequently 61050 and 38480 g/mol. During the 16 weeks follow-up, the 
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molecular weights decreased to 27 560 and 12730 g/mol, respectively. At the same 
time, the crystallinity increased in both e.o. and g.i. groups. 
 
Experimental study using the sheep model (III) 
The plates had an initial shear strength of 107.2 ± 14.8 MPa. At week 16, the shear 
strength had decreased to 78.2 ± 15.4 MPa. Subsequently the shear strength could not 
be measured because of the fragility of the material. Because of processing and gamma 
irradiation the inherent viscosity of the plate material was 1.44 dl/g although that of the 
raw material had been 8.27 dl/g. Inherent viscosity decreased with implantation time to 
0.64 dl/g in 16 weeks and to 0.24 dl/g in 36 weeks. On the basis of enthalpy change, the 
initial crystallinity was 1.5%. Crystallinity increased steadily up to 29% at week 36. At 
the same time the molecular weight decreased from 48725 to 4186 g/mol (Figure 11 
and 12). 
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Figure 11. 
Sheep model. Change in Mv molecular weight (white columns) and crystallinity (black 
columns) with time.  Data characteristic of SR PLDLA stereocopolymers with an isomer ratio 
of 96/4. 
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Figure 12. 
Sheep model. Changes in shear strenght with time. Data characteristic of SR PLDLA 
stereocopolymers with an isomer ratio of 96/4. 
 
Experimental study using the rat model (VI) 
Gel Permeation Chromatography (GPC) 
The molecular weights (Mw) of P(L/D)LA 96/4 and P(L/DL)LA 70/30 are in Figure 13. 
The Mw and Mn of PDS (Figure 14) decreased by over 50% during the first month. The 
rate of decrease during the second month was very similar. 
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Figure 13. 
Rat model. Changes in two components of the SR PLDLA 96/70 composite implant. Change in 
weight-average molecular weights (Mw) of SR P(L/DL)LA 70/30 and SR P(L/D)LA 96/4 
material  with time. 
 
 
Figure 14. 
Rat model. Changes in molecular weights (Mw and Mn) of PDS with time. 
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Differential Scanning Calorimetry (DSC) 
Changes in the crystallinity of SR P(L/D)LA 96/4 and SR P(L/DL)LA 70/30  are 
shown in Figure 15. The crystallinity of the originally amorphous SR P(L/DL)LA 70/30 
started to increase at month 5. By contrast, the crystallinity of SR P(L/D)LA 96/4 
decreased. The Tm of SR P(L/D)LA 96/4 and SR P(L/DL)LA 70/30 varied in vivo but 
no increase or decrease was observed. However, Tg showed a decreasing trend over  
five months, followed by a slight increase. The pattern was similar with PDS, but the 
decrease continued for three months. The increase of crystallinity of PDS over time is 
shown in Figure 16.  
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Figure 15. 
Rat model. Changes in the crystallinity of two components of the SR PLDLA 96/70 composite 
implant. SR P(L/DL)LA 70/30 and SR P(L/D)LA 96/4 materials plotted against time.  
 
 
 
Figure 16. 
Rat model. Relative changes in the crystallinity of PDS with time. The initial value is assumed 
to be 100.  
 
 
5.1.4. Histology and immunohistochemical findings 
Experimental study using the rabbit model (I) 
All the SR PLDLA 85/15 implants were enveloped by a connective tissue capsule 
consisting mainly of fibroblast-like cells. Some macrophages, lymphocytes and 
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polymorphonuclear leukocytes were observed, suggesting a low-grade chronic 
inflammation. In 36 and 48 weeks specimens, pseudosynovial membrane-like tissue 
interfacing implants was detected. No differences were seen between capsules of the 
gamma-irradiated or ethylene oxide-sterilized implants.  
During the first 36 weeks there was an intense reactivity for both tenascin and cellular 
fibronectin. An intense reactivity for cellular fibronectin and α-actin persisted to the 
end of the study around the implant material. Immunostaining of smooth muscle α-actin 
demonstrated a thick layer of activated myofibroblasts in areas presenting cellular 
fibronectin and tenascin immunoreactivities.  
 
Experimental study using the sheep model (III) 
At the week 12, the fibrous capsules around SR PLDLA 96/4 contained fibroblasts and 
inflammatory cells. The week 36 specimen showed fibrocartilagenous areas around all 
capsules. 
Widespread reactivity for tenascin was detected in the connective tissue against implant 
surfaces on week 12 specimens. Cellular fibronectin was diffusely present in the 
connective tissue, and the pattern of immunoreactivity was comparable to that for 
tenascin. The reactivities for tenascin and cellular fibronectin became more restricted at 
weeks 22 and 36 and were observed in the immediate vicinity of the implant. 
 
Experimental study using the rat model (VI) 
The capsules around all three types of implant consisted of two zones: an inner, thin, 
cell-rich zone and an outer, dense, connective tissue zone containing a few fibroblast-
like, spindle-shaped cells (Figures 17 A and B.).  
 
 
 
Figures 17 A and B. 
Rat model: A thin cell-rich zone is detected 
on the surface of the implant. 
Black arrow = implant; black arrow / large 
arrow = cell-rich inner zone; transparent 
arrow / large arrow = outer dense 
connective tissue zone. 
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After two months PDS fragments were in close contact with a thin inner zone 
containing numerous mononuclear cells and giant cells. At the 5 month follow-up, the 
capsules, which had earlier been found to consist of a single compartment, were divided 
by numerous thin walls. The changes in SR PLDLA 96/70 during follow-up were 
minor. Tenascin expression was local and restricted with both SR PLDLA 96/70 and 
PDS (Figure 18). Triple staining showed that tenascin expression occurred in the inner 
cell-rich zone near the implant surface. In contrast to tenascin, α-actin was present in 
dense connective tissue zones throughout the follow-up and formed belt-like structures 
around but a little apart from the degrading implants.  
 
 
 
 
 
Figure 18. 
Rat model: Immunofluorescence micro-
graphs. Moderate amounts of tenascin 
around SR PLDLA 96/70 at month 7 
(original magnification 400 x). 
 
There was a highly significant difference (P< 0.0001) between type I and type III 
collagen positivity around all implants (Figure 19). Type III collagen expression in the 
inner zone was almost 20 times stronger than in the outer zone, whereas that of the type 
I collagen was exactly the opposite. However, there were no significant differences in 
type I and type III collagen positivities either between different follow-up times 
(p>0.05) or between PDS and SR PLDLA 96/70 (p>0.05) implant materials. 
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Figure 19.  
Rat model. Note the clear difference in 
expression of type III collagen in the inner 
zone vs. outer zone of the capsule. SR 
PLDLA 96/70 implant, 7 months, type III 
collagen staining. 
 
The T-lymphocyte density increased as a function of time around both materials but no 
statistically significant differences were found between PDS and SR PLDLA 96/70 
(p>0.05) implants or between the inner and outer zones. Monocytes/macrophages 
showed an increase in density during the follow-up but no statistically significant 
differences were found. Both SR PLDLA 96/70 and PDS specimens followed the same 
pattern and no significant differences were found between them (p>0.05). 
 
5.1.5. Transmission and scanning electron microscopy findings 
Experimental study using the rabbit model (I) 
In specimens examined by TEM the SR PLDLA 85/15 material were occasionally 
found to be surrounded by a layer of amorphous-like material. 
 
Experimental study using the rat model (VI) 
Degradation of the SR P(L/D)LA 96/4 and SR P(L/DL)LA 70/30 materials began to be 
visible in SEM at month 7. There were cracks in perpendicular direction to the long 
axis of the filaments. This was observed in the filaments of the SR P(L/D)LA 96/4 
throughout the implant (Figure 20). This cracking was observed at the outer curve of 
the filament loop, where tension is the fracturing force.  
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Figure 20.  
Rat model. SEM image of SR P(L/D)LA 
96/4 filament. Cracks (arrows) of 
perpendicular orientation at month 7. Scale 
bar 10 µm.     
 
 
SR P(L/DL)LA 70/30 was also observed to have degraded strongly by month 7. The 
surface of the plate showed the same kind of changes in some parts and was detached 
from the porous core in some places (Figure 21). The surface layer of the material 
showed evidence of degradation. 
 
 
 
 
Figure 21.  
Rat model. SEM image of SR P(L/DL)LA 
70/30 plate surface. A fragment has 
detached from the surface and the inner 
porous structure is seen at month 7. Scale 
bar 100 µm. 
 
 
PDS was also seen to have degraded strongly in the SEM observations. The 
degradation was observed as particles detaching from the PDS plates.  
 
5.2. Clinical studies (II, IV) 
5.2.1. Clinical results with the resorbable PDS implant (II) 
Sixteen consecutive patients, 11 males and 5 females were included in this study. The 
mean age of the patients was 39.2 (18.0 - 58.9) years for men and 31.3 (20.1 - 53.2) 
years for women. The majority of the patients had been injured by interpersonal 
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violence (n=9 / 56%). Out of the 16 internal orbital wall fractures, ten were pure 
blowout fractures of the floor and six were associated with a nondislocated zygomatic 
fracture. 
Preoperatively two patients (13%) had enophthalmos of more than 2 mm. The number 
of enophthalmic patients increased to six at the end of the study (Figure 22). The 
pattern of occurrence of hypoophthalmos was similar to the pattern of enophthalmos. 
There were no statistically significant differences between reconstructions using sheets 
or plates in relation to hypo-ophthalmos or enophthalmos.  
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Figure 22. 
Total number of patients with enophthalmos and proptosis of more than 2 mm during the 
clinical follow-up examinations after orbital floor reconstruction with PDS. 
 
In one patient there was prolonged oedema in the lower lid region. At the 16th 
postoperative week, this patient developed an ipsilateral maxillary sinusitis with general 
symptoms. When the plate was removed several small PDS fragments were found 
inside the dense connective tissue capsule. 
 
5.2.2. Clinical results with autogenous iliac crest graft (IV) 
Twenty-four consecutive patients, 15 males and 9 females with unilateral orbital wall 
fractures were enrolled in the study. The mean age of the patients was 37.3 years (17.2 - 
54.8 years). The main aetiology was assault (58%). Out of 24 patients 11 (46%) had 
pure orbital floor fracture and six (25 %) had an associated nondislocated zygomatic 
fracture.  
Preoperatively, two (8%) patients had enophthalmos, and one (4 %) had hypo- 
ophthalmos of 2 mm or more. At the last follow-up, enophthalmos was detected in one 
 
 
 58
patient (4%, Figure 23), two (8%) had hyperophthalmos but five (21%) had hypo-
ophthalmos. 
Diplopia was registered preoperatively in 18 patients (75%). At the last follow-up, none 
of the patients presented diplopia in the central field of vision. The restrictions in eye 
movement resolved themselves and at the end of the follow-up no one had clinically 
detectable restrictions. However, 10 patients (42%) reported a subjective feeling of 
double vision in some direction of gaze.  
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Figure 23. 
Total number of patients with enophthalmos and proptosis of 2 mm or more during each 
clinical follow-up after iliac crest graft floor reconstruction. 
 
One patient with medial wall and floor fracture was operated on twice. After the first 
operation, the globe was 2 mm proptotic but 3 mm hypo-ophthalmic. He was 
reoperated on and at the one-week follow-up the globe was slightly enophthalmic and 
hypo-ophthalmic. After eight months, the position of the globe had again deteriorated 
with 3 mm hypo-ophthalmos and 2 mm enophthalmos. 
 
5.2.3. Radiographic findings 
Resorbable PDS (II)  
CT confirmed bone growth in the orbital floor, but new bone formation was detected in 
the fractured area, i.e. along the fractured floor, but not in the area where the PDS 
bridged the defect.  As a consequence, the fractured floor on the final CT scan was 
similar to that seen on the CT taken before operation, and no repositioning of 
intraorbital tissue could be seen as a result of the plate. No long-term reduction in 
orbital volume therefore occurred (Figure 24). In one patient a possible orbitonasal 
fistula without clinical symptoms was observed at 13 weeks follow-up. 
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Figure 24. 
PDS reconstruction. CT image 36 weeks  
postoperatively, volume and shape of orbit 
have not been restored. 
 
 
No clear muscle herniations (entrapment) within the fracture area were observed in 
MRI or CT studies. The inferior rectus muscle was always surrounded by thick orbital 
fat. MRI revealed adverse peri-implant reactions in 10 cases (63%). These peri-implant 
lesions were 8 mm in thickness and were situated in the area of the implanted plate. 
Only one of these lesions resolved itself totally during the study.  
In the patient with prolonged oedema in the lower lid region and an ipsilateral 
maxillary sinusitis with general symptoms, CT and MRI confirmed a large cystic 
formation inside the orbit and phlegm retention in the sinus. 
  
Autogenous bone graft (IV) 
Bone grafts were visualized well by CT imaging.  At one-week follow-up CT imaging 
demonstrated that the orbital floor in the middle section was well elevated in 18 orbits 
(75%).  
In three orbits (13%) the posterior part of the graft was hanging 5 mm caudally. In six 
orbits (25%) the angle of the graft was graded as poor. The graft was at the wrong angle 
coronally in five and sagittally in four cases leading to an enlarged orbital volume in 
five (21%) orbits. At the last follow-up CT imaging showed that in one orbit the graft 
was still in an over-elevated position. All grafts were either moderately (79%) or mildly 
(21%) resorbed, but none had totally disappeared (Figures 25 A and B). On the other 
hand, new bone growth was observed in 75% of the cases.  
Comparing with CT, MRI gave a more accurate view of the position of the soft tissue 
relative to bone. No muscle herniation was noted. In 15% of the orbits periorbital fat 
was seen protruding through the remaining bone defects. No maxillary sinus irritation 
was seen at the last visit. In the patient with the re-reconstructed orbital walls, CT and 
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MRI confirmed a good position and only moderate resorption of the bone.of the iliac 
grafts. 
 
 
 
 
 
 
 
 
 
Figures 25 A and B. 
Autogenous bone graft reconstruction 
(arrow) of the left orbital floor; A. 2 
months after operation coronal CT shows 
resorption of the graft. B. 6 months after 
operation the graft has resorbed further. 
Note moderate ossification laterally in the 
area between the graft and the original 
orbital floor. 
 
 
5.3. Finite element analysis (V) 
Orbital displacement 
Each simulated missile impact (blunt injury) caused the orbit to deform in a different 
way. Antero-lateral views from the FEM analysis are shown in Figures 26 A-E.  
 
 
 
 
 
B. Missile impact from 45° upward (MU). 
Maximum displacement = 91.3 mm 
A. Missile impact from the front (MOR). 
Maximum displacement = 117.8 mm 
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Figures 26. A, B, C, D, E.  
Antero-lateral view of the FEM in its non-deformed (black) and deformed (red) states during 
various simulations. Green indicates maximum deformation affecting the postero-medial part of 
the orbital floor. The display of the deformed state was magnified 10 times and the globe was 
omitted to make the distinction more evident. 
 
The missile impact was simulated at right angles from the front to the orbital rim 
(MOR), 450 upwards (MU), 450 downward (MD), 450 right (MR) and 450 left (ML). 
The non-deformed state in each figure depicts the model with its structural elements in 
their unloaded condition. The deformed state is one in which the action of the missile 
displaced the structural elements, and the model has reached the state of static 
equilibrium. Displacement has been magnified in the figures to make orbital 
deformation more evident. When the missile was directed from the front or from 450 
C. Missile impact from 45° downwards (MD). 
Maximum displacement = 100.7 mm 
D. Missile impact from 45° right (MR).
Maximum displacement = 75.6 mm 
E. Missile impact from 45° left (ML).
Maximum displacement = 55.7 mm 
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downwards, the orbit deformed in the anti-clockwise direction, and the lateral wall bent 
upwards and inwards, indicating orbital rotation. If the missile was directed from 450 
right or from 450 left, the right and left sides of the orbit deformed turning anti-
clockwise and clockwise respectively. If the missile was directed from 450 upwards, the 
lateral and medial walls were displaced in an outward direction, rather than being 
rotated, indicating less orbital rotation than from the impact coming from downwards 
and at right angles from the front.  
 
Orbital stresses 
Stress values ranged from 112.1 to 262.3 MPa for the maximum principal stress, from  
– 123.7 to – 552.1 MPa for the minimum principal stress, and from 111.3 to 343.3 MPa 
for the maximum shear stress (Table 8). In all cases the maximum stress occurred in the 
postero-medial part of the orbital floor (Figures 27 A and B.).  
Table 8.  
Maximum stress values predicted by the FEM analysis during simulated orbital injuries. 
MAXIMUM STRESS 
(MPa) Direction of the missile impact  with a 30 m/s velocity 
 
45° 
Upwards 
45° 
Downwards 
45° 
Right 
45° 
Left 
Maximum Principal 112.1 262.3 158.2 162.3 
Minimum Principal -226.8 -552.1 -123.7 -152.1 
Maximum Shear 
 
111.3 343.3 129.8 233.3 
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                       A.                                                                 B. 
Figure 27.  
A. Deformation shown in the form of a vector display of maximum principal stress. The highest 
values (blue arrows) affected the postero-medial part of the orbital floor.   
B. Maximum principal stress bands on the orbit when subjected to a blunt injury from a missile 
velocity 30 m/s, directed at right angles from the front to the orbital rim. Coloured numbers 
reflect stress magnitudes. To enhance the distribution patterns of principal stresses on the 
cortical surface of the orbit, the stresses were displayed at lower ranges of magnitude.  
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Orbital floor stresses 
Special attention was given to the orbital floor stress analysis due to its importance in 
the treatment of orbital trauma. Stresses were quantified for loads (missile) coming at 
right angles from the front to the orbital rim (MOR), 450 upwards (MU), 450 
downwards (MD), 450 (MR) and 450 (ML). In all cases, the impact coming from right 
and from left evoked the lowest stress magnitudes (Figures 28 A – D). 
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C. 
 
 
 
 
 
 
 
 
D. 
 
Figure 28.  
Principal (A and D) and maximum (C) shear stress magnitudes at the orbital floor during 
various simulations. Stress values were plotted at 18 nodes forming the cortical outline of the 
orbital floor (B.). Nodes 2 to 9 were located on the anterior (A) aspect of the orbital floor 
outline and nodes 11 to 18 on the posterior (P) side. 
 
Maximum principal stress was higher at the posterior aspect of the orbital region than 
anteriorly during all simulations except the upwards impact, which resulted in higher 
magnitudes of stress at the anterior region of the floor. In all cases, the lowest values 
were found at the most lateral/medial sides. Minimum principal stresses had peaks of 
intensity at the anterior aspect of the orbital floor during upwards, downwards and at 
right angles from the front impacts. The magnitudes of maximum shear stress were 
approximately symmetrically distributed between the anterior and the posterior aspects 
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of the orbital floor region during all simulations except that in which the load was 
applied at right angles from the front to the orbital rim, which caused higher shear on 
the anterior orbital floor. 
The average, maximum and total force magnitudes for 36 nodes forming the cortical 
outline of the postero-medial part of the orbital floor, during various simulations, are 
shown in Table 9. Although slightly dissimilar in total magnitude, the orbital forces 
were similar when the load was applied at right and left angulations. When the load was 
directed at the orbital rim at right angles from the front, in upwards or in downwards 
angulation, the postero-medial region experienced the highest average and total forces 
overall.  
 
Table 9.  
The average, maximum and total forces (Newton) are given for 36 nodes forming the 
cortical outline of the postero-medial part of the orbital floor. 
Orbital 
Force (N) Direction of the missile velocity 30 m/s  
 From the 
front at right 
angles 
45° 
Upwards 
45° 
Downwards 
45° 
Right 
45° 
Left 
Average 8.4 8.2 7.9 6.3 6.4 
Maximum 8.9 8.4 8.0 7.6 7.8 
Total 
 
199.3 187.0 182.1 175.0 176.0 
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6. DISCUSSION 
Reconstruction of the orbital floor with bioresorbable materials is a controversial 
subject. No material has yet proven to be successful without any complications in 
clinical work. One of the main issues is the maintenance of the initial 3-dimensional 
shape of the implant. To achieve this, the implant needs to resist coiling and 
deformation and to be strong enough to tolerate the pressure exerted by the orbital 
content without being passively moulded. Another important issue is biocompatibility. 
The ideal material should have biological and physical properties that replicate those of 
the tissue it replaces. The material should be permanently accepted by the host, unless 
the implant material degrades completely within accetable time limits.  
The material and biological properties of four different bioresorbable implants and 
autogenous iliac bone grafts were assessed in this study. Assessment of the implants 
involved a macroscopic evaluation, determination of strength and molecular weight and 
thermal and SEM analysis. Host response was assessed using TEM and 
immunohistochemistry. We chose tenascin, cellular fibronectin, α-actin-containing 
myofibroblast, type I collagen and type III collagen as biological markers for several 
reasons. Tenascin plays a role in the development of granulation tissue, in cell 
migration and in tissues undergoing active remodelling (Mackie et al. 1988, Luomanen 
and Virtanen 1993). In wounds, a marked transient increase has been detected in the 
expression of tenascin and cellular fibronectin (Luomanen and Virtanen 1991, 1993, 
Raghow 1994). Myofibroblasts play an important role in connective tissue capsule 
formation and maintenance, in particular capsular contraction (Welch et al. 1990). They 
generate the force that results in contraction of the capsule surrounding the implant 
(Welch et al. 1990). Collagen bundles also seem to be part of the tethering system that 
links the wound matrix to the surrounding tissues, enabling contractile forces to be 
transmitted across the wound or around the implant (Welch et al. 1990, Lossing and 
Hansson 1993).  
 
Strength retention and reconstruction properties of polydioxanone and polylactide 
implants 
PDS 
Merten and Luhr (1994) reported that PDS looses 50% of its strength during the first 
postoperative month. We found that the PDS implant lost its shape completely during 
the first few postoperative weeks. Our results showed that the molecular weight of the 
 
 
 68
PDS decreased by over 50% during first month and by a further 50% during the second 
month, indicating a rapid loss of strength. This parallels other studies, in which the 
strength of the PDS plate was 50% of its original value four weeks after implantation 
and only 25% after five weeks (Hidding et al. 1991). Mäkelä and coworkers (2002) 
compared the breaking strength of SR PLLA, PDS and polyglyconate sutures of 0.3 – 
0.5 mm in diameter. While SR PLLA retained its tensile strength up to 10 months, the 
PDS suture lost its tensile strength completely within five months. Highest percentage 
elongation of straight sutures (62%) was exhibited by PDS. For this reason PDS sutures 
have not been recommended for wound closure needing prolonged support such as 
bone.  
Enophthalmos is generally detected in 30 – 70% of patients after blowout fracture 
(Greenwald et al. 1974, Bartkowski and Krzystkowa 1982, Kranau et al. 1991). In the 
present study only 13% had enophthalmos preoperatively. This is probably because 
preoperative examinations were performed on average only a few days after trauma 
when the swelling had not yet resolved. This is supported by the observation that at the 
end of the study almost half of the patients had enophthalmos or hypo-ophthalmos. 
Other research groups have reported similar high rates of enophthalmos in orbits 
reconstructed with  PDS (Dietz et al. 2001, Baumann et al. 2002). These results seem to 
be slightly worse than in studies in which allogenic dura or nonresorbable implants 
have been used (Greenwald et al. 1994, Friesenecker et al. 1995).  
Sixty years ago Pfeiffer (1943) noted that loss of bone support led to enophthalmos. 
However, loss of ligament support, fat atrophy and scar contracture may also lead to 
similar symptoms (Putterman 1991).  We used CT and MRI imaging to try to establish 
the reasons for the high degree of enophthlmos after PDS reconstruction. While CT 
revealed new bone formation over the fracture area, the shape of the fractured floor and 
its craniocaudal height showed no marked change from the preoperative situation. On 
the other hand, MRI scans showed no fat herniation into the maxillary sinus. This 
suggests that the globe support during the healing period was inadequate and the 
volume of the orbit was not actually corrected. The fact that PDS degrades rapidly and 
loses much of its strength during the first few weeks is probable reasons for this. PDS is 
not able to withstand the pressure caused by orbital content. The scar that forms after 
implant resorption is too weak and thin to provide adequate support to the globe and to 
compensate for the enlarged orbital volume. 
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Although Merten and Luhr (1994) recommended PDS implants for reconstruction even 
large and anatomically demanding orbital defects, they reported that only 
morphologically intact implants had osteoconductive capabilities and that the resorbed 
PDS implants were replaced only by a tight scar tissue. Many studies suggest that PDS 
should only be used for minor orbital floor fractures (Iizuka et al. 1991, Baumann et al. 
2002).  Our study further supports this conclusion. 
 
Polylactides 
All resorbable SR PLDLA 96/4 and 85/15 copolymer implants coiled and fractured in 
our study. This significant degree of coiling was unexpected and has not previously 
been reported when plates are used for facial fracture treatment. Polylactide implants 
have been used for orbital floor reconstruction since 1972, when Cutright and Hunsuck 
(1972) published their study on their use in experimental fractures in rhesus monkeys. 
Since then there have been several studies on polylactide implants in orbital wall 
reconstruction (Rozema et al. 1990, de Roche et al. 2001) and in subcutaneous tissue 
(Cordewener et al. 1995) but none of them has reported any coiling. There have been 
no reports of coiling or deformation of SR strengthened plates in cases where the plates 
were symmetrically fixed with screws or pins (Suuronen 1993, Haers et al. 1998). 
However, in the orbital region such a symmetrical fixation of the plate both anteriorly 
and dorsally is not possible for anatomical reasons, which probably goes someway to 
explaining this difference. 
The other main difference between the present and other studies on orbital implants is 
in the technique used to reinforce, i.e. strengthen, the plates. The material in our study 
was strengthened using the SR technique. Others have used the s.c. as-polymerized 
PLLA or PLDLA technique without strengthening (Rozema et al. 1990, Cordewener et 
al. 1996). 
In the study by Rozema and coworkers (1990) PLLA sheets were used to reconstruct 
the orbital floors of goats. The authors reported that the orbital floors healed completely 
during the 78 weeks follow-up. At that time the plates were not yet fully disintegrated. 
Similar plates were later used in the reconstruction of orbital floor fractures in six 
patients (Cordewener et al. 1996). At the end of the follow-up time of between 3.5 and 
6.5 years none of the patients reported any problems. MRI studies showed no abnormal 
tissue reactions or implant deformities in the orbital region. The authors concluded that 
PLLA orbital floor implants can be successfully used in the repair of human orbital 
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floor defects. The main drawback of PLLA is its very long degradation time, which is 
why it has not been recommended for orbital wall reconstruction (Bergsma et al. 1993, 
Andriano et al. 1994). 
PLDLA stereocopolymers have been developed to shorten the degradation time of 
PLA-based implants. The degree of crystallinity and strength retention can be 
modulated by changing the optic isomer (L/DL) ratio. In vitro the degradation time of 
the PLDLA has been shown to be shorter than that of pure PLLA, yet its strength 
properties are comparable to those of pure PLLA (Andriano et al. 1994). On the other 
hand, some major unfavourable changes related to the mechanical and physical 
properties of PLDLA stereocopolymers, such as rapid loss of strength, have been 
reported to occur during the first few weeks after in vivo implantation (Cordewener et 
al. 1995). 
The present experimental study examined the suitability of resorbable SR PLDLA 96/4 
and 85/15 copolymer implants for orbital floor reconstruction. Unfortunately, the 
mechanical and physical properties of these plates were poor. When the orbital floor 
was reconstructed with the SR PLDLA 96/4 implant, no differences were seen in 
healing between the reconstructed and control orbital floors. As with PDS, copolymers 
loose their strength much faster than PLLA homopolymer. The shear strength of SR 
PLDLA 96/4 polymer decreases by about 30% from its initial value in 16 weeks. 
Thereafter the shear strength could not even be measured because of the fragility and 
particulation of the implant material. The tensile strength of SR PLDLA 85/15 was not 
measurable after four weeks. This parallels the studies by Cordewener and coworkers 
(1995). Thus, these materials cannot be safely used for orbital floor reconstruction, 
either. The decrease in shear strength and subsequent resorption occur too early and, 
hence, the plate cannot tolerate the pressure caused by the orbital content.  
Clinically, the orbits showed better ossification than was expected based on 
radiological imaging. This was due to the fact that the bone formed was very thin and 
not always visible in radiographs. Therefore, the problem seems not to be that the 
orbital floor does not ossify, as this seems to happen. However, bone heals too caudally 
and results in a further and harmful increase in orbital volume.  
To avoid these problems, and in particular to avoid coiling, a new SR (P(L/DL)LA 
96/70 orbital-floor implant was designed composed of a frame of 70/30 L/DL-lactide 
copolymer and 96/4 L/D-lactide copolymer mesh sheet.  
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The SR P(L/D)LA 96/4 mesh of the implant seems to degrade more slowly than the SR 
P(L/DL)LA 70/30 frame. During the first three months the molecular weights 
decreased only by 25 %, both materials having the same molecular weight at that time. 
But after seven months follow-up the molecular weights decreased to 50% (SR 
P(L/D)LA 96/4) and to 20% (SR P(L/DL)LA 70/30). The change in crystallinity of 
both materials was only minor. This was expected according to the literature on SR 
strengthened polylactide copolymers (Pohjonen 1995) and the results are better than of 
those for as-polymerized L/D polylactides (Cordewener et al. 1995). On the other hand, 
in scanning electron microscopy, both SR-P(L/DL)LA materials degraded significantly 
during the 7-month follow-up in vivo. The surface of the plate showed significant 
changes and became partially detached from the porous core during that time. Cracking 
was observed at the outer curve of the filament loop. The findings parallel other 
published reports (Pohjonen 1995). During the follow-up there were no signs of 
deformation or coiling. The mechanical and physical properties seem to be suitable for 
orbital floor reconstruction, but further studies are needed to validate these preliminary 
findings. 
 
Biocompatibility of polydioxanone and polylactide implants 
Many clinical and experimental studies have concluded that biodegradable PDS 
implants are well tolerated in the orbital region (Merten and Luhr 1994), although 
contradictory publications exist. There are numerous reports of adverse foreign body 
reactions related to PDS (de Roche et al. 1998, Baumann et al. 2002). Capsules 
surrounding breast implants removed due to complications seem to be composed of two 
zones, an inner cell-rich zone and an outer dense connective tissue zone (Lossing and 
Hansson 1993). This organization of peri-implant tissues into an inner zone and a dense 
outer fibrous zone was detected around PDS implants in our study, too. The inner cell-
rich zone resembled granulation tissue and was of restricted localization. Degrading 
implant crystals generate a foreign body type reaction leading to capsule formation (de 
Roche et al. 1998). The mechanism controlling the formation of the capsule and the 
reactive and adaptive changes associated with it are not known.  It has been proposed 
that the local enrichment of growth factors, which are beneficial for acute wound 
healing, in the chronically irritated tissue around resorbing implants support adverse 
tissue reactions (Lossing and Hansson 1993).   
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Using MRI imaging we demonstrated a foreign body reaction and fluid accumulation in 
more than half of the patients with a PDS orbital wall implant. Our experimental studies 
showed an increase in inflammatory cells in the capsule around the PDS implant, 
indicating a foreign body reaction. These results confirm those reported by de Roche 
and coworkers (1998) and Bar and coworkers (1992).  
We were able to demonstrate a perpetuated expression of the extracellular matrix 
proteins tenascin, cellular fibronectin and also of α-actin (active myofibroblasts) in the 
capsule around PDS. The basic reasons for this are obscure. The simultaneous 
reactivity for tenascin, collagen type III and active myofibroblasts is a very important 
issue. This finding of prolonged persistance of granulation tissue is a sign of an active 
and ongoing process around the biodegradable PDS implant and should be considered 
when the clinical use of this material is contemplated for the orbital reconstruction. 
An inner cell-rich zone and a dense outer zone of the capsule were also detected around 
all polylactide copolymer implants. The inner zone appeared in the very early phase. 
Cells were attached to the implant surface and were continuously in contact with the 
implant material. Only a mild foreign body reaction was detected. Expression of all the 
ECM proteins studied was demonstrated in the connective capsule around polylactide 
implants. The finding of two different zones coincided well with these tissue markers. 
The cell-rich zone corresponded with the expression of tenascin and collagen type III, 
whereas the outer connective tissue zone was characterized by the expression of 
collagen type I and α-actin. The presence of tenascin, cellular fibronectin and collagen 
type III in the zone immediately surrounding implants has also been noted in other 
studies (Lindholm et al. 1996, Shannon et al. 1997). 
During wound healing tenascin is expressed in the granulation tissue, where it declines 
just before the wound heals completely (Luomanen and Virtanen 1993). Similar results 
were obtained in the present study. Wound contraction and contraction of the capsule 
around the implant have been shown to be attributed to the activity of myofibroblasts, 
which are rich in α-actin bundles (Lossing and Hanson 1993, Shannon et al. 1997). 
Some but not all fibroblast-like cells in dense connective tissue zones synthesize α-actin 
(Welch et al. 1990). In the present study, considerable α-actin reactivity (active 
myofibroblasts) was found in the outer zone of the PLDLA capsule. They formed a 
tight belt around the implant and the inner cell rich zone in contact with it throughout 
the study period.  
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Several experimental and clinical studies have been conducted on the biocompatibility 
of SR polylactides. Except for a low-grade foreign body reaction they have proved to 
be well tolerated (Vainionpää et al. 1989, Suuronen 1993, Gogolewsky et al. 1993). In 
the present study no adverse reactions to polylactide copolymers were noted, except for 
fluid accumulation in the implant capsule. The fluid reflects a typical, non-specific, 
foreign body reaction without signs of infection, supporting the results of earlier studies 
(Böstman et al. 1992, Thaller et al. 1995). However, the prolonged appearance of 
granulation tissue with increased ECM protein reactivity reflects a prolonged, active 
process around the biodegradable implant and should be taken into consideration in the 
clinical use of polylactide materials. 
 
Reconstruction properties of autogenous iliac bone grafts 
Autogenous bone grafting has been the gold standard providing framework for the 
facial skeleton and orbital walls. Bone grafting is the method of choice for correction of 
posttraumatic globe malposition (Roncevic and Malinger 1981, Hemprich and Breier 
1993, Siddique and Mathog 2002).  
Many different sources of autogenous bone such as calvarium, mandibular and 
maxillary bone, ribs, and iliac crest are available (Lee et al. 1998, Mintz et al. 1998, 
Dempf et al. 2001, Siddique and Mathog 2002, Ellis and Tan 2003). In the study by 
Ellis and Tan (2003) calvarium bone was compared with titanium mesh in 38 patients 
for internal orbital wall reconstruction. They concluded that both titanium mesh and 
calvarium bone can be successfully used for reconstruction of isolated blowout 
fractures. However, there was significant variance in the cross-sectional area of the 
anterior region of the orbit. Furthermore, because of its brittleness, calvarium bone 
could not be contoured to adapt to the complex structure internal orbit. Dempf and 
coworkers (2001) used calvarial and iliac crest grafts in repairing osseous orbital 
defects. Of 42 patients 34 were followed up for at least four months. They concluded 
that with autogenous bone transplants, good aesthetic and functional results can be 
achieved, and that autogenous grafts can be broadly recommended. Calvarium split 
grafts were particularly suitable for this purpose. Both Bartkowski and Krzystkowa 
(1982) and de Visscher and van der Wal (1988) used iliac crest grafts for orbital floor 
and medial wall reconstruction. Both study groups concluded that autogenous 
corticocancellous bone, like iliac crest, is extremely well tolerated and is suitable for 
orbital wall reconstruction. On the other hand, an iliac crest graft is said to be bulky 
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unless trimmed and it may resorb unpredictably (Roncevic and Malinger 1981). 
Resorption of iliac bone grafts used for orbital wall reconstruction has been clearly 
documented (Sullivan et al. 1993, Iatrou et al. 2001, Siddique and Mathog 2002). 
Basically there are two forms of free autogenous bone graft: cortical and cancellous 
(Burchardt 1983). They differ in their mechanical properties. The mechanical strengths 
of cancellous and cortical grafts correlate with the respective repair process: cancellous 
grafts tend to strengthen first, whereas cortical grafts become weaker (Burchardt 1983). 
In the present study corticocancellous bone grafts were used. The results of the 
resorption were consistent with earlier studies. In 80% of the orbits major resorption 
was observed. However, the height of the graft was poor in only two (11%) out of those 
orbits. On the other hand, when only mild resorption of the graft was observed, the 
height of the graft was poor in 20% of those orbits.  
At the end of the follow-up the outcome of the bony reconstruction was graded poor in 
25% of orbits. In those orbits in which the orbital volume had increased, the angulation 
of the graft was improper. At the same time new bone growth was observed in 75% of 
orbits. This suggests that, on the one hand, at least to some extent, resorption and 
remodelling of the corticocancellous graft is anatomically beneficial and on the other 
hand that exact primary 3-dimensional correction of the fractured walls and correct 
angulation of the graft are very important for an adequate anatomic outcome. It is 
notworthy that intraoperatively the iliac graft was moldable and after trimming was 
easily adapted to the shape and form of the internal orbital wall. 
 
The principal mechanism of posttraumatic enophthalmos and hypo-ophthalmos is 
enlargement of the volume of the orbit (Pfeiffer 1943, Manson et al. 1986). In the 
present study using iliac bone graft reconstruction only one patient had enophthalmos 
and five (21%) had hypo-ophthalmos after the follow-up. These results are satisfactory 
and well parallel to other studies (Greenwald et al. 1974, Bartkowski and Krzystkowa 
1982, de Visscher and van der Wal 1988, Friesenecker et al. 1995). In the five cases, in 
which enlarged volume of the orbit was observed, the bone graft was placed too 
caudally in the posterior floor area. This coincides well with the study by Ellis and Tan 
(2003).  
In the present study group, one patient needed a reoperation because of inadequate 
primary graft placement. In spite of the good radiological results after rereconstruction, 
his final clinical outcome was unsatisfactory. Meticulous analysis of both MRI and CT 
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images did not reveal the exact reason for the false position of the globe. This 
experience emphasizes the significance of succesful primary correction. 
The study by Iatrou and coworkers (2001) reported that hypo-ophthalmos remains in 
the most severe cases despite of moderately good bone graft reconstruction. They 
suggested that the reason for this is the unfavourable bone resorption. Dempf and 
coworkers (2001) reported 30% hypo-ophthalmos rate after orbital wall reconstruction, 
although the reconstruction was rated anatomically poor in only 2% of cases. They used 
calvarial and iliac crest grafts to repair osseous orbital defects. In the present study 
moderate or major bone resorption was observed in 80% of orbits. Clinically these 
patients had no enophthalmos. This parallels well above mentioned studies and is 
indicative of the favourable mechanical properties of iliac bone grafts. 
Overcorrection of the fracture area is recommended by Iatrou and coworkers (2001). In 
the present study only one patient had clinically demonstrated hyperophthalmos. He 
was the only one, whose graft was in an overcorrected position. Although the number 
of patients is small in this study, it seems reasonable to assume that fresh blowout 
fractures do not need to be overcorrected with an iliac bone graft, but the graft should 
be positioned accurately.    
 
Donor site disadvantages of autogenous iliac bone grafts 
The disadvantages of autogenous iliac bone grafts include donor site nerve and blood 
vessel injuries, acute and chronic pain, gait problems, and cosmetic disturbances. 
Although multiple sites can be used harvest autogenous grafts, the anterior iliac crest 
remains the most popular donor site (St John et al. 2003). Despite the large volume of 
autologous iliac crest grafts used, donor site morbidity seems to be low. A study by 
Banwart and coworkers (1995) revealed that none of the 261 patients studied had a 
severe perioperative complication and none of the 225 patients in a long-term follow-up 
had a severe late complication. The authors concluded that severe complications from 
iliac crest bone graft harvesting can be avoided by proper surgical methods and that 
major complications affecting function are uncommon, although minor complications 
are relatively common. Ahlmann and coworkers (2002) reported similar results in their 
study of 66 anterior iliac sites. Major complications were seen in 8% and minor ones in 
15%. In our study the most common complication was a visible skin scar. Five patients 
(20%) ended up having a visible scar in this area. The incision in the iliac crest area 
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should be carefully planned, especially in female patients. Although the rate seems to 
be low, donor site complications should not be ignored. 
 
Diplopia and orbital wall reconstruction 
Patients who experience true diplopia naturally are quite troubled by this symptom and 
nearly always present this as their chief complaint. Basically, diplopia may be 
monocular or binocular. The two most common hypotheses for binocular double vision 
and impaired eye movement are contusion injury to the extraocular muscles or soft 
tissues and incarceration of these structures to the fracture line (Converse and Smith 
1967, Putterman et al. 1974). Our patients had double vision in most cases in upward 
gaze, and movement limitation upwards. This can be explained by these two 
mechanisms. 
MR imaging has been reported to be sensitive for orbital fat, orbital muscles and 
haematoma (Manfre et al. 1993, Zhan et al. 1995). In the present study all these 
structures were clearly visualized by MRI. On the intact orbital floor, the orbital fat 
faced the straight bony floor. Therefore, the flat inferior rectus muscle was well 
visualized leaning on the orbital floor. On the fractured side the orbital fat protruded as 
a round mass into the maxillary sinus. The inferior muscle was considerably rounded 
compared to flat-shaped muscle at the uninjured site, giving an impression of being 
oedematous. MR imaging demonstrated the presence of a thin fat layer between the 
fractured bone and the inferior muscle. When preoperative MRI and CT taken from the 
same fracture were compared, no trap door fracture or muscle incarceration was 
documented and neither was seen in postoperative CT or MRI scans. In addition, 
postoperative MRI showed that infraorbital tissue was well repositioned on top of the 
bone graft.  
Diplopia was seen more often immediately postoperatively (84%) than preoperatively 
(75%). This is probably due to iatrogenic surgical injury, e.g. slight haemorrhage, 
contusion, postoperative oedema and scar formation. MRI revealed that the inferior 
rectus muscle was still oedematic in 44% of the patients at the last visit, which, 
however did not correlate with diplopia. No correlation could be established between 
the position of the bone graft and diplopia in this study. Operation delay did not affect 
the occurrence of postoperative diplopia, either. This parallels other studies, suggesting 
that diplopia is multicausative rather than the result of an increase in orbital volume, 
contusion or incarceration only. Early surgery is not necessary for treatment of diplopia 
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if no evidence of entrapment is detected (Catone et al. 1988, Putterman 1991). The 
present findings agree well with this conclusion. 
A forced duction test is used if incarceration on intraorbital soft tissue or 
ophthalmoplegia is suspected. Kupersmith and Fazzone (2004) evaluated three portable 
methods for documenting ocular muscle limitation that might be used at multiple sites 
in a clinical trial. They concluded that the intra-examiner repeatability of measurements 
was high but considerably less than the intra-examiner repeatability in all three test 
methods. Although the forced duction test was neither included in the study protocol 
nor studied, it was found beneficial in cases where ophthalmoplegia was suspected.  
 
Finite element modelling 
Although treatment of orbital fractures has a moderate success rate, the long-term 
clinical significance of orbital deformation through implant treatment is still unknown. 
The possibility that traumatic orbital deformation and the resulting stresses may lead to 
implant failure cannot be excluded. FE modelling provides insights into the 
understanding of this multifaceted phenomenon, which has relevance to clinical 
practise.  
A review of the literature showed that several three-dimensional finite element models 
of the eye and/or orbit have been created (Kobayashi et al. 1971, Power 2001). 
Generally speaking, the reliability of their predictions for modelling has been severely 
compromised by oversimplification of the orbital geometry, material properties and/or 
boundary conditions. The accuracy of a finite element model (FEM) in predicting 
strains directly depends on the accuracy of these effectors in the environment.  
The anterior aspect of the orbital floor was affected most at lower magnitudes of 
principal stresses than the posterior aspect. This might be explained by the cushioning 
effect of the eyeball and underlying fatty tissues, which provides an ideal stress-
breaking mechanism to minimize orbital deformation. This highlights the importance of 
restoring the fatty tissue during orbital floor reconstruction following an orbital blowout 
fracture. Our investigation confirms reports by Waterhouse and coworkers (1999), that 
the buckling mechanism produces fractures in the posterior and postero-medial aspects 
of the orbital floor and that, in contrast to the result expected from the hydraulic 
mechanism, medial wall involvement is infrequent. According to the buckling theory, 
direct trauma to the orbit may cause transient deformation of the infraorbital rim. This 
is transmitted to the thinner orbital floor causing its disruption without a fracture of the 
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rim. The hydraulic theory, in contrast, proposes that the hydraulic pressure from the 
globe is transmitted to the walls of the orbit, resulting in fracture of the orbital floor.   
The qualified usefulness of the finite element model developed in this study lies in the 
facts that a) it modelled bone as an orthotropic material, b) the model was loaded with 
experimentally obtained muscular forces, c) it was mathematically validated, and 
sensitivity analysis was used throughout to enhance the equivalency of the model to a 
real human orbit. It is this detailed and comprehensive approach that gives the model a 
reliability that has so far been missing in the finite element models reported in the 
literature. However, finite element modelling and its applications in the management of 
orbital fractures are still in their infancy.  New research is going on in this field and we 
hope to come up with better materials or methods to treat the challenging problem of 
orbital wall fracture.  
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7. CONCLUSIONS 
The following conclusions can be drawn from the results obtained in the present 
studies: 
1.  Mechanically, PDS sheets are poor as they loose their shape and integrity 
completely within a few weeks. The molecular weight of PDS falls 
rapidly already during the first month. Degradation of PDS is seen as 
detaching particles from the plate surface. After two months PDS folio 
degrades into hard, sharp pieces. Peri-implant reactions such as thick scar 
tissue formations and fibrotic sinuses appear. A PDS implant does not 
restore the orbital volume, nor does it provide adequate support for orbital 
contents. Posttraumatic enophthalmos or hypo-ophthalmos can not be 
prevented. 
 
2. With the exception of SR PLDLA 96/70 mesh sheet – frame composites, 
the mechanical properties of polylactide implants are not suitable for 
orbital wall reconstruction. Both SR PLDLA 85/15 and 96/4 implants lose 
their strength too fast. Macroscopical examination shows that both these 
implants are severely deformed after a few weeks. On the other hand, the 
molecular weights of SR P(L/D)LA  96/4 and SR P(L/DL)LA 70/30 
decrease slowly and, accordingly, an SR PLDLA 96/70 composite 
implant maintains its shape adequately. The mesh sheet - frame structure 
seems to be mechanically adequate for orbital wall reconstruction. 
 
3. All the cell markers (Tn, cFn, α-actin and type I and type III collagen) 
studied here are expressed widely in the connective tissue capsule 
forming around PDS and polylactide materials. Their expression 
continues throughout the whole observation period, indicating an 
ongoing, long-term host response. There seems to be no differences 
between SR PLDLA, SR PLDLA 96/70 composite and PDS implant 
materials in relation to the immunohistochemical findings studied here, 
indicating that the response is directed against the bulky implant per se, 
rather than being dependent on its exact physicochemical properties. The 
cell-rich interface zone, together with the increased reactivity of the 
markers, indicates an active process around the biodegradable implants 
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and should be taken into account when the clinical use of these materials 
is being considered. It seems that PDS gives rise to inflammatory 
reactions. Although these reactions are usually mild, often even clinically 
unnoticed, it is obvious that the use of this material carries with it the risk 
of severe inflammatory complications.This may be an issue with all 
biodegradable materials.  
 
4. Reconstruction of the orbital wall with an autologous iliac bone graft is 
reliable. It restores the volume and the shape of the orbit well. The 
resorption rate is high, but most of it is beneficial remodelization. The 
graft is rigid enough to support the orbital contents and facilitates new 
bone growth across the orbital wall defect. Autogenous bone grafts have 
obvious advantages over the resorbable materials studied here. 
 
5. Our study group constructed and reports a finite element model that 
represents the human orbit housing the eyeball and its associated 
structures. The stresses and forces required to produce an orbital fracture 
are for the first time numerically modelled. However, more work must be 
done to study the effects of changing the geometrical relationships, 
material properties and boundary conditions on stress/strain readings and 
their role in successful fracture treatment. 
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8. SUMMARY 
Autogenous bone grafts provide the "gold standard" for orbital reconstructions. 
However, they are rather complex to use in routine clinical praxis. This problem could 
be overcome by the use of alloplastic material, which is readily available and easy to 
handle. However, alloplastic materials have been used with caution, because they can 
provoke unpredictable foreign body reactions. It is this background that led us to 
investigate the clinical performance and biocompatibility of these materials to be able 
to create evidence and recommendations for their use in the reconstruction of orbital 
wall fractures.  
Three sets of experiments were undertaken. These were experimental, clinical and finite 
element analysis studies. In the experimental studies we used four different implant 
models in 10 rabbits, 18 sheep and 24 rats to examine the biocompatibility of three 
different self-reinforced polylactide stereocopolymers (SR PLDLA 96/4, SR PLDLA 
85/15, SR PLDLA 96/70 composite) and polydioxanone (PDS®) implants. The study 
protocol included CT imaging, immunohistochemistry and electron microscopy. The 
clinical studies included two different models using a bone graft and a PDS® plate as 
implant material. In the first clinical study 24 consecutive internal orbital wall fractures 
were reconstructed using autogenous iliac crest bone grafts. In the second clinical 
study, 16 consecutive fractures were repaired using PDS® sheets. These study protocols 
consisted of clinical examinations and CT and MRI imaging. A finite element model 
(FEM) was constructed of the human orbit, including the eye, fatty tissues and extra-
ocular muscles. The orbit was subjected to a blunt impact from a 0.5 kg missile striking 
the orbit at 30 m/s at different angles. The finite element model was then used to predict 
principal and shear stresses / strains at each node position. 
In the experimental studies, all SR PLDLA and PDS® implants, except the SR PLDLA 
96/70 composite implants, became severely deformed during the follow-up. After two 
months the PDS folio had degraded into hard, sharp pieces and the SR PLDLA 
implants had broken after a few weeks. The strength of SR PLDLA implants decreased 
rapidly and after a few months could not be measured. In contrast, the SR PLDLA 
96/70 composite implants maintained their shape and strength throughout the whole 
observation period of seven months. All the implants were enveloped by a connective 
tissue capsule, consisting mainly of fibroblast-like cells. A low-grade chronic 
inflammation was observed. There was an intense reactivity for Tn, cFn and smooth 
muscle α-actin.  
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In the clinical studies, when PDS implants were used to reconstruct the orbital wall 
fracture, MRI revealed adverse peri-implant reactions in 10 cases (63%). No such 
lesions, i.e. foreign body reactions, were detected when autogenous bone grafts were 
used. CT imaging showed that there were no differences in the size or shape of the 
defects pre- and postoperatively when PDS implants were used. This agreed with the 
findings of the experimental studies. All free bone grafts were partially resorbed, but 
new bone growth was observed in 75% of the orbits and the volume of the orbit was 
restored. After PDS reconstruction of internal orbital wall fracture about 40% of the 
patients had enophthalmos. Following bone graft reconstruction, only one patient (4%) 
had enophthalmos.  
The finite element analysis study demonstrated two types of orbital deformation: a) 
horizontal distortion and b) rotational distortion. Stress values ranged from 112.1 to 
262.3 MPa for maximum principal stress, from –123.7 to –552.1 MPa for minimum 
principal stress, and from 111.3 to 343.3 MPa for maximum shear stress.  
In short, reconstruction of the orbital walls was most reliable using autogenous iliac 
bone graft. It restored the volume and the shape of the orbit well. Autogenous bone 
grafts have obvious advantages over alloplastic resorbable materials. Of the resorbable 
implants studied here, only the mesh sheet and frame structure of the SR PLDLA 96/70 
proved to be mechanically adequate for orbital wall reconstruction. There were no 
differences between polylactide implant materials and PDS implants in terms of 
immunohistochemical findings. The simultaneous increase in the reactivity of cell 
markers is an important issue related to the bioresorbable materials studied here, but 
this may also be the case with all biodegradable materials. The finite element model 
constructed is the first one reported that represents the human orbit housing the eyeball 
and its associated structures. In this study, the stresses and forces required to produce 
an orbital fracture were measured with reasonable reliability for the first time.  
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